{"title":"MOOM","description":"","products":[{"product_id":"oxytocin-10mg","title":"(❤️ “Love Hormone”) Oxytocin Peptide - 10mg - 10 Vials","description":"\u003cdiv class=\"et_pb_tab_content\"\u003e\n\u003cdiv class=\"pro-description-con\"\u003e\n\u003cp\u003eIt is best known as:\u003cbr\u003e❤️ “Love Hormone”\u003cbr\u003eor\u003cbr\u003e🤱 “Bonding Hormone”\u003c\/p\u003e\n\u003cp\u003eBecause it is associated with:\u003c\/p\u003e\n\u003cp\u003eIntimate relationships\u003cbr\u003eSocial connections\u003cbr\u003eTrust\u003cbr\u003eChildbirth\u003cbr\u003eBreastfeeding\u003c\/p\u003e\n\u003cp\u003eIn conventional medicine, Pitocin is a synthetic form of oxytocin, commonly used for:\u003c\/p\u003e\n\u003cp\u003eInducing labor\u003cbr\u003eInducing delivery\u003cbr\u003ePostpartum hemorrhage control\u003cbr\u003e🧬 The Effects of Oxytocin\u003c\/p\u003e\n\u003cp\u003eOxytocin is not just the “love hormone.”\u003c\/p\u003e\n\u003cp\u003eIt actually influences:\u003c\/p\u003e\n\u003cp\u003eEmotions\u003cbr\u003eSocial behavior\u003cbr\u003eStress response\u003cbr\u003eThe reproductive system\u003cbr\u003eUterine contractions\u003cbr\u003eThe lactation reflex\u003cbr\u003e❤️ Why It’s Called the “Love Hormone”\u003c\/p\u003e\n\u003cp\u003eBecause research has found that:\u003c\/p\u003e\n\u003cp\u003eIn humans:\u003c\/p\u003e\n\u003cp\u003eHugging 🤗\u003cbr\u003ePhysical intimacy\u003cbr\u003eSexual activity\u003cbr\u003eMother-infant interaction\u003c\/p\u003e\n\u003cp\u003eOxytocin levels rise.\u003c\/p\u003e\n\u003cp\u003eTherefore, many people believe it is associated with:\u003c\/p\u003e\n\u003cp\u003eTrust\u003cbr\u003eEmotional connection\u003cbr\u003eSocial comfort\u003c\/p\u003e\n\u003ch3\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3\u003eOxytocin Peptide\u003c\/h3\u003e\n\u003cp style=\"margin-bottom: 30px;\" class=\"white-back-d\"\u003eOxytocin is a small peptide comprising only nine amino acids, naturally produced in the hypothalamus and secreted by the posterior pituitary gland cells. It has also been isolated from placenta, ovaries, testes, adrenal glands, thymus, retina, and pancreas tissues. The active hormone is obtained by proteolytic cleavage of a larger precursor protein. It is no longer considered merely a neurohypophyseal hormone as its actions are considered to be far-reaching and include interaction with additional peptides. Oxytocin appears to be a protein with two independent natural functions. First, it appears to act as a neuropeptide produced by the hypothalamus to regulate bonding, reproduction, and birth. Oxytocin appears to be bloodborne and secreted by the placenta of pregnant animals to influence birth, milk production, and bonding with their young. Small amounts of the protein produced from testes may promote mating behavior and pair bonding.\u003c\/p\u003e\n\u003ch3\u003eSpecifications\u003c\/h3\u003e\n\u003cp class=\"grey-back\"\u003e\u003cstrong\u003eOther Known Titles:\u003c\/strong\u003e Endopituitrina, Pitocin\u003c\/p\u003e\n\u003cp class=\"white-back\"\u003e\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e C\u003csub\u003e43\u003c\/sub\u003eH\u003csub\u003e66\u003c\/sub\u003eN\u003csub\u003e12\u003c\/sub\u003eO\u003csub\u003e12\u003c\/sub\u003eS\u003csub\u003e2\u003c\/sub\u003e\u003c\/p\u003e\n\u003cp class=\"grey-back\"\u003e\u003cstrong\u003eMolecular Weight:\u003c\/strong\u003e 1007.19 g\/mol\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 30px;\" class=\"white-back\"\u003e\u003cstrong\u003eSequence:\u003c\/strong\u003e Cys-Tyr-lle-Gln-Asn-Cys-Pro-Leu-Gly\u003c\/p\u003e\n\u003ch3\u003eOxytocin Research\u003c\/h3\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eOxytocin and Wound Recovery\u003c\/strong\u003e\u003cbr\u003eOxytocin appears to regulate inflammation through inflammatory cytokines. Increased social interaction in one research study was observed to trigger Oxytocin (Pitocin) levels, which researchers speculated may have led to faster tissue repair and wound recovery. Similarly, studies in hostile equations between animals appear to suppress oxytocin production and delay wound recovery, potentially by up to 40%.\u003csup\u003e[1]\u003c\/sup\u003e The researchers conclude, \"\u003cem\u003eThese data confirm and extend prior evidence implicating oxytocin and vasopressin in positive and negative communication behaviors, and also provide further evidence of their role in an important [variable].”\u003c\/em\u003e These hostile couples also exhibited reduced IL-6, tumor necrosis factor-alpha, and IL-1beta at the wound site.\u003csup\u003e[2]\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eOxytocin and Cardiovascular Risk\u003c\/strong\u003e\u003cbr\u003eThe hormone has been speculated to protect cardiac and vascular systems. It may act to dissipate and burn off fat cell accumulation, influence blood pressure and glucose intolerance, and potentially block or mitigate the secretion of stress hormones.\u003csup\u003e[3]\u003c\/sup\u003e These factors may influence cardiovascular disease (CVD); thus, Oxytocin (Pitocin) may be a potential compound in the study of CVD. Reduced Oxytocin receptors may cause atherosclerosis.\u003csup\u003e[4]\u003c\/sup\u003e The primary scientist in the cited study reports that \u003cem\u003e“The major pathophysiological basis of CAD is atherosclerosis in association with varieties of immunometabolic disorders that can suppress oxytocin (OT) receptor (OTR) signaling in the cardiovascular system (CVS).”\u003c\/em\u003e Oxytocin exposure appears to overcome the drawback of reduced receptor density and helps maintain cardiac integrity. Exposure of the peptide in rodent hearts during a heart attack appeared to assist in preventing the cellular death of cardiomyocytes. Jankoski et. al. suggested that chronic Oxytocin (Endopituitrina) exposure may address late-term development of dilated cardiomyopathy.\u003cbr\u003e\u003cbr\u003eIt also appears to help to prime the cardiac stem cells for “\u003cem\u003etissue regeneration through direct differentiation, secretion of protective and cardiomyogenic factors, and\/or their fusion with injured cardiomyocytes\u003c\/em\u003e.” It further appears to mitigate cases of cardiac damage due to diabetes in mice. The fat accumulation in these mice was reported to be reduced by 19%, and the fasting glucose levels by about 23%. Oxytocin (Endopituitrina) appears to increase insulin resistance in the animals, possibly establishing proper systolic and diastolic functions over control animals, leading to decreased cardiomyocyte hypertrophy, fibrosis, and apoptosis.\u003csup\u003e[5]\u003c\/sup\u003e It also appears to protect against ischemic injuries in other tissues as well, outside of the heart. Studies in rat models of priapism indicate the potential action of Oxycotin (Pitocin) against ischemia-reperfusion injury by reducing nitric oxide levels.\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eOxytocin and Diabetes\u003c\/strong\u003e\u003cbr\u003eThe peptide appears to improve skeletal muscles' glucose uptake by boosting insulin sensitivity. It may further support lipid utilization, dyslipidemia, and fat mass reduction. Oxytocin deficiency has also been suggested to correlate to body mass, irrespective of external factors, suggesting its role in energy homeostasis.\u003csup\u003e[6]\u003c\/sup\u003e Oxytocin appears to affect insulin, glucose, and body composition in obese mice but not lean mice. Research observations suggest that the peptide might be impactful only in certain conditions; for instance, the backdrop of diabetes appears to trigger different actions in diabetes models compared to controls. As per Barengolts, “\u003cem\u003ecirculating oxytocin is lower in type 2 diabetes versus normoglycemic subjects and negatively correlated with glycosylated hemoglobin A1C and insulin resistance.\u003c\/em\u003e“\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eOxytocin and Cognitive Performance\u003c\/strong\u003e\u003cbr\u003eMaternal deprivation may induce irreversible cognitive and behavioral functioning changes. Studies in murine models suggest Oxytocin changes due to decreased parental bonding may be a prominent cause. Oxytocin exposure in maternally deprived mice appeared to increase hormone levels for neuronal development in the prefrontal cortex. Overall behavior appeared to remain constant, but the cognitive ability was observed to be improved in the cohort exposed to Oxytocin.\u003csup\u003e[7]\u003c\/sup\u003e The researchers therefore felt they had grounds to speculate that Oxytocin may improve learning in mice under stress.\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eOxytocin Peptide Research and Anxiety\u003c\/strong\u003e\u003cbr\u003eThe hormone has been studied for its potential to minimize anxiety and depression. The genetic polymorphisms in the Oxytocin (Endopituitrina) receptor gene related to anxiety disorder and problems with attachment. Animals exhibiting chronic anxious behavior have also displayed epigenetic changes in the Oxytocin receptor.\u003csup\u003e[8]\u003c\/sup\u003e This indicates a possible compensatory pathway for pathologically suppressed Oxytocin levels. This indicates that anxiety may be partially induced by diminished Oxytocin signaling.\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eOxytocin and Hunger\u003c\/strong\u003e\u003cbr\u003eResearch on a condition marked by uncontrolled appetite has suggested that at least part of the pathology may result from increased suppression of Oxytocin (pitocin) signaling.[9] Therefore, Oxytocin (Endopituitrina) has been suggested to potentially regulate the state of hunger in the organism and its feeding behavior.\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eOxytocin and Old Muscle\u003c\/strong\u003e\u003cbr\u003eOxytocin also appears to regulate muscle maintenance. Age-associated reduction in molecule levels appears to lead to muscle wasting (sarcopenia). The research carried out at Berkeley suggests that both blood levels of the peptide and its receptors on muscle stem cells decrease over time. Exogenous exposure to Oxytocin appears to allow muscles to recover much of their potential. According to Elabd, one of the authors of the study, \u003cem\u003e“repair of muscle in the old mice was at about 80%”\u003c\/em\u003e compared to younger mice after Oxytocin was presented.\u003csup\u003e[10]\u003c\/sup\u003e Thus, it can potentially be studied in relation to organ degeneration further, as it may slow down dysfunction.\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eOxytocin and Neurotransmitter Regulation\u003c\/strong\u003e\u003cbr\u003eOxytocin is posited to engage with G-protein coupled receptors, which may increase intracellular calcium levels and, therefore, might regulate neurotransmission and excitation.\u003csup\u003e[11]\u003c\/sup\u003e Further, Oxytocin's potential influence on the brain may extend to neurogenesis and synaptic plasticity, which may impact the intricate formation and function of neural circuits. The presence of Oxytocin receptors across various neural cell types hints at the peptide's broad potential impact, possibly modulating the behavior of neural progenitor cells and influencing the fate of these cells. Oxytocin might also affect newly formed neural circuits by modulating neurotransmitter dynamics, including those of glutamate and gamma-aminobutyric acid (GABA), which serve as the brain's primary excitatory and inhibitory signals.\u003cbr\u003e\u003cbr\u003eAt the synaptic level, Oxytocin's actions appear to diverge, potentially enhancing neurotransmitter release in some contexts while diminishing it in others. This dual action may reflect Oxytocin's potential to modulate the balance between excitation and inhibition within the neural circuits, a balance considered crucial for maintaining the functional integrity of the brain. Such modulation may manifest through alterations in the release of neurotransmitters or changes in membranes, indirectly influencing neuronal excitability and the flow of neural information. The interactions of Oxytocin with glial cells, such as astrocytes, further complicate its role in neurotransmitter dynamics, suggesting a broader regulatory influence that extends beyond the neurons to the supportive environment that nurtures and maintains synaptic connections. This interaction may influence the synaptic plasticity and overall function of neural circuits, offering a glimpse into the complex regulatory roles Oxytocin might play in the neural ecosystem.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 30px;\" class=\"grey-back-d\"\u003e\u003cstrong\u003eOxytocin and Sexual Behavior\u003c\/strong\u003e\u003cbr\u003eOxytocin is hypothesized to potentially influence sexual behavior by modulating dopamine activity in central nervous system regions believed integral to the reward system, specifically the ventral tegmental area (VTA) and the nucleus accumbens.\u003csup\u003e[12]\u003c\/sup\u003e More specifically, the peptide may enhance dopamine release or increase the responsiveness of dopamine-releasing neurons. Such alterations in dopaminergic activity may conceivably elevate sexual drive and support the perception of reward, thereby playing a role in the anticipatory behaviors associated with mating and copulation.\u003cbr\u003e\u003cbr\u003eThe interaction between Oxytocin and these neurons may trigger a cascade of biological events leading to a significant release of dopamine in the nucleus accumbens. One component of this cascade might involve nitric oxide production within the VTA, suggesting a complex interaction between Oxytocin, dopamine, and nitric oxide in this context.\u003cbr\u003e\u003cbr\u003eFurthermore, Oxytocin might also exert indirect action on dopamine levels in other brain regions, such as the hippocampus and amygdala, thus contributing to its multifaceted role in modulating behavior. These indirect actions might regulate the activities of neurons that release glutamate or GABA, neurotransmitters that may then influence the activity of dopaminergic neurons in the VTA and nucleus accumbens. Such a mechanism underscores the intricate and potentially widespread influence of Oxytocin on brain functions related to sexual behavior.\u003cb\u003e\u003cem\u003e\u003c\/em\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003ch3 style=\"color: #555;\"\u003eReferences\u003c\/h3\u003e\n\u003cdiv style=\"margin-bottom: 30px;\" class=\"white-back-d\"\u003e\n\u003col style=\"color: #555;\"\u003e\n\u003cli\u003eGouin JP, Carter CS, Pournajafi-Nazarloo H, Glaser R, Malarkey WB, Loving TJ, Stowell J, Kiecolt-Glaser JK. Marital behavior, oxytocin, vasopressin, and wound healing. Psychoneuroendocrinology. 2010 Aug;35(7):1082-90. . Epub 2010 Feb 9. PMID: 20144509; PMCID: PMC2888874.\u003c\/li\u003e\n\u003cli\u003eKiecolt-Glaser JK, Loving TJ, Stowell JR, Malarkey WB, Lemeshow S, Dickinson SL, Glaser R. Hostile marital interactions, proinflammatory cytokine production, and wound healing. Arch Gen Psychiatry. 2005 Dec;62(12):1377-84. . PMID: 16330726.\u003c\/li\u003e\n\u003cli\u003eReiss AB, Glass DS, Lam E, Glass AD, De Leon J, Kasselman LJ. Oxytocin: Potential to mitigate cardiovascular risk. Peptides. 2019 Jul;117:170089. . Epub 2019 May 18. PMID: 31112739.\u003c\/li\u003e\n\u003cli\u003eWang P, Wang SC, Yang H, Lv C, Jia S, Liu X, Wang X, Meng D, Qin D, Zhu H, Wang YF. Therapeutic Potential of Oxytocin in Atherosclerotic Cardiovascular Disease: Mechanisms and Signaling Pathways. Front Neurosci. 2019 May 21;13:454. . PMID: 31178679; PMCID: PMC6537480.\u003c\/li\u003e\n\u003cli\u003ePlante E, Menaouar A, Danalache BA, Yip D, Broderick TL, Chiasson JL, Jankowski M, Gutkowska J. Oxytocin treatment prevents the cardiomyopathy observed in obese diabetic male db\/db mice. Endocrinology. 2015 Apr;156(4):1416-28. . Epub 2015 Jan 6. PMID: 25562615.\u003c\/li\u003e\n\u003cli\u003eDing C, Leow MK, Magkos F. Oxytocin in metabolic homeostasis: implications for obesity and diabetes management. Obes Rev. 2019 Jan;20(1):22-40. . Epub 2018 Sep 25. PMID: 30253045; PMCID: PMC7888317.\u003c\/li\u003e\n\u003cli\u003eDayi A, Kiray M, Sisman A, Ozbal S, Baykara B, Aksu I, Uysal N. Dose dependent effects of oxytocin on cognitive defects and anxiety disorders in adult rats following acute infantile maternal deprivation stress. Biotech Histochem. 2019 Oct;94(7):469-480. . Epub 2019 May 20. PMID: 31104534.\u003c\/li\u003e\n\u003cli\u003eZiegler C, Dannlowski U, Bräuer D, Stevens S, Laeger I, Wittmann H, Kugel H, Dobel C, Hurlemann R, Reif A, Lesch KP, Heindel W, Kirschbaum C, Arolt V, Gerlach AL, Hoyer J, Deckert J, Zwanzger P, Domschke K. Oxytocin receptor gene methylation: converging multilevel evidence for a role in social anxiety. Neuropsychopharmacology. 2015 May;40(6):1528-38. . Epub 2015 Jan 7. PMID: 25563749; PMCID: PMC4397412.\u003c\/li\u003e\n\u003cli\u003eAtasoy D, Betley JN, Su HH, Sternson SM. Deconstruction of a neural circuit for hunger. Nature. 2012 Aug 9;488(7410):172-7. . PMID: 22801496; PMCID: PMC3416931.\u003c\/li\u003e\n\u003cli\u003eElabd C, Cousin W, Upadhyayula P, Chen RY, Chooljian MS, Li J, Kung S, Jiang KP, Conboy IM. Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration. Nat Commun. 2014 Jun 10;5:4082. . PMID: 24915299; PMCID: PMC4512838.\u003c\/li\u003e\n\u003cli\u003eBakos, Jan et al. “Molecular Mechanisms of Oxytocin Signaling at the Synaptic Connection.” Neural plasticity vol. 2018 4864107. 2 Jul. 2018, \u003ca rel=\"noopener\" href=\"https:\/\/doi.org\/10.1155\/2018\/4864107\" target=\"_blank\"\u003edoi: 10.1155\/2018\/4864107\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eMelis, Maria Rosaria, and Antonio Argiolas. “Oxytocin, Erectile Function and Sexual Behavior: Last Discoveries and Possible Advances.” International journal of molecular sciences vol. 22,19 10376. 26 Sep. 2021, \u003ca rel=\"noopener\" href=\"https:\/\/doi.org\/10.3390\/ijms221910376\" target=\"_blank\"\u003edoi: 10.3390\/ijms221910376\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"vbni\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"author-details\"\u003e\n\u003ch2\u003e\u003ca href=\"https:\/\/biotechpeptides.com\/dr-marinov\/\"\u003eDr. Usman\u003c\/a\u003e\u003c\/h2\u003e\n\u003cp\u003eDr. Usman (BSc, MBBS, MaRCP) completed his studies in medicine at the Royal College of Physicians, London. He is an avid researcher with more than 30 publications in internationally recognized peer-reviewed journals. Dr. Usman has worked as a researcher and a medical consultant for reputable pharmaceutical companies such as Johnson \u0026amp; Johnson and Sanofi.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"mysite","offers":[{"title":"Default Title","offer_id":51786428252477,"sku":"sku2194756143847","price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0997\/4474\/3741\/files\/Oxytocin-10MG-2-1.webp?v=1780466136"},{"product_id":"dsip-5mg","title":"(🧠 Improves sleep structure) DSIP (Delta Sleep-Inducing Peptide) (5mg) -10 Vials","description":"\u003cdiv class=\"et_pb_tab_content\"\u003e\n\u003cdiv class=\"pro-description-con\"\u003e\n\u003cp\u003e🌙 1️⃣ Improves sleep structure\u003c\/p\u003e\n\u003cp\u003eSome studies and user reports suggest that DSIP may:\u003c\/p\u003e\n\u003cp\u003eIncrease deep sleep (delta wave sleep)\u003cbr\u003eReduce the time it takes to fall asleep\u003cbr\u003eEnhance the feeling of sleep recovery\u003cbr\u003e🧠 2️⃣ Anti-stress effects\u003c\/p\u003e\n\u003cp\u003eIn some animal studies:\u003c\/p\u003e\n\u003cp\u003eReduced stress response\u003cbr\u003eRegulation of the HPA axis\u003c\/p\u003e\n\u003cp\u003eIt is therefore classified as:\u003cbr\u003e👉 “Anti-stress peptide”\u003c\/p\u003e\n\u003cp\u003e⚡ 3️⃣ Neuroregulation\u003c\/p\u003e\n\u003cp\u003eMay affect:\u003c\/p\u003e\n\u003cp\u003eThe GABA system\u003cbr\u003eCircadian rhythms\u003cbr\u003eMelatonin-related pathways (speculated)\u003c\/p\u003e\n\u003ch2\u003eDSIP (Delta Sleep-Inducing Peptide)\u003c\/h2\u003e\n\u003cp class=\"white-back-d\" style=\"margin-bottom: 30px;\"\u003eDSIP is a naturally occurring neuropeptide made of 9 amino acids that may influence diverse endocrine and physiological pathways involved in the central nervous system. DSIP is of key interest as it was developed to help combat oxidative stress and normalize myocardial contractility. The peptide is considered a potential research candidate in studies of major depressive disorder. Delta sleep-inducing peptide (DSIP) is a naturally occurring peptide of short length. The molecule’s name came about due to researchers’ speculation of its potential to induce sleep in rabbits and because it was first isolated from the brains of rats during slow-wave sleep (in 1977).\u003csup\u003e[1]\u003c\/sup\u003e Slow Wave Sleep (SWS), often referred to as deep sleep, is considered a pivotal phase within the overall sleep architecture, which is composed of non-rapid eye movement (NREM) sleep and rapid eye movement (REM) sleep. Sleep architecture itself exhibits a cyclical pattern, typically oscillating between NREM and REM phases multiple times throughout the duration of total sleep. Predominantly classified under the NREM sleep category, SWS is characterized by its distinctive low-frequency, high-amplitude delta brainwaves, as observed in electroencephalogram (EEG) recordings. The sleep cycle initiates with NREM sleep, which is further divided into three phases: N1, N2, and N3. The initial stages, N1 and N2, represent lighter sleep phases, whereas N3, equated with SWS, signifies the deepest phase of sleep. Upon completion of the deep sleep phase, the cycle transitions to REM sleep, marked by heightened brain activity and dreaming. Researchers have gradually explored its function in different endocrine and physiological roles. In addition to its potential influence on sleep patterns, DSIP appears to influence levels of corticotropin, inhibit the production of somatostatin, reduce stress hormone secretion, maintain normal blood pressure, alter sleep patterns and also may impact pain perception.\u003csup\u003e[2]\u003c\/sup\u003e\u003c\/p\u003e\n\u003ch3\u003eSpecifications\u003c\/h3\u003e\n\u003cp class=\"grey-back\"\u003e\u003cstrong\u003eOther Known Titles: \u003c\/strong\u003eDelta Sleep-Inducing Peptide\u003c\/p\u003e\n\u003cp class=\"white-back\"\u003e\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e C\u003csub\u003e35\u003c\/sub\u003eH\u003csub\u003e48\u003c\/sub\u003eN\u003csub\u003e10\u003c\/sub\u003eO\u003csub\u003e15\u003c\/sub\u003e\u003c\/p\u003e\n\u003cp class=\"grey-back\"\u003e\u003cstrong\u003eMolecular Weight:\u003c\/strong\u003e 848.82 g\/mol\u003c\/p\u003e\n\u003cp class=\"white-back\" style=\"margin-bottom: 30px;\"\u003e\u003cstrong\u003eSequence:\u003c\/strong\u003e Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu\u003c\/p\u003e\n\u003ch3\u003eDSIP Research\u003c\/h3\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eDSIP and Potential Mechanisms\u003c\/strong\u003e\u003cbr\u003eDSIP is purported to influence the structure and quality of sleep through its interactions with the central nervous system. It is speculated that DSIP may shorten the onset of sleep and enhance sleep quality by modulating the activity of several neurotransmitters in the brain. However, the precise mechanisms and pathways by which DSIP operates remain unclear.\u003cbr\u003e\u003cbr\u003eOne hypothesis suggests that DSIP targets specific receptors that play a pivotal role in its actions. These receptors include the N-methyl-D-aspartate (NMDA) receptors and gamma-aminobutyric acid (GABA) receptors. NMDA receptors are associated with glutamate, an essential excitatory neurotransmitter in the brain, while GABA receptors are linked to inhibitory neurotransmission, which is considered crucial for reducing neural activity and inducing a relaxed state. Experimental studies on murine models indicate that DSIP may enhance the inhibitory actions of GABA, thereby reducing neural excitability and facilitating the onset of sleep.\u003csup\u003e[3]\u003c\/sup\u003e These studies also suggest that DSIP could attenuate the excitatory actions of NMDA receptors, further contributing to its sleep-promoting properties.\u003csup\u003e[4]\u003c\/sup\u003e\u003cbr\u003e\u003cbr\u003eMoreover, research points to a possible interaction between DSIP and opioid receptors in the brain, which may play a role in the peptide’s ability to regulate sleep and mitigate withdrawal symptoms, underscoring its intricate role in neural signaling pathways.\u003csup\u003e[5,6]\u003c\/sup\u003e Additionally, the alpha 1-adrenergic receptor, located in the pineal gland, has emerged as a potential target in DSIP-related research. Preliminary findings suggest that DSIP’s modulation of this receptor may influence sleep patterns and possibly aid in stress management, given the receptor’s significant consideration in stress response processes. These insights emphasize the complex and varied potential ways in which DSIP might impact sleep and stress, though further investigation is essential to fully delineate its biological functions and research potential.\u003csup\u003e[7]\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eDSIP and Stress\u003c\/strong\u003e\u003cbr\u003eIn one scientific investigation, the action of DSIP on murine models subjected to controlled stress scenarios has been explored.\u003csup\u003e[4]\u003c\/sup\u003e This inquiry largely examined the variations in levels of substance P, beta-endorphin, and corticosterone—key biomarkers relevant for decoding the stress response and the potential regulatory actions of DSIP. Preliminary results indicated that exposure to DSIP may lead to significant alterations in the concentrations of these indicators, which may imply a role in modulating stress. Specifically, an initial reduction followed by a substantial increase in beta-endorphin levels was observed, a pattern that suggests DSIP’s impact on the opioidergic system, potentially playing a role in stress alleviation or adaptation processes. Furthermore, a reduction in corticosterone levels was recorded soon after exposure to DSIP. These observations suggest that the actions of DSIP on substance P, beta-endorphin, and corticosterone are indicative of a wider array of biochemical modifications, proposing that DSIP may trigger a cascade of molecular events that may facilitate its stress-modulatory functions.\u003csup\u003e[4]\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eDSIP and Sleep Activity\u003c\/strong\u003e\u003cbr\u003eExtensive research has been conducted to establish the connection between the peptide and sleep. Despite the initial findings in rabbits, it was tough to establish the pattern in which DSIP may affect sleep. In some findings, it did not appear to influence sleep at all.\u003csup\u003e[8]\u003c\/sup\u003e In some, the peptide favored Slow Wave (SWS) paradoxical sleep. Interestingly, there were other groups whose research noted that the molecule appeared to cause arousal in the first hour of sleep, followed by sedation in the second hour of sleep. In totality, it was observed that DSIP may help to bring about a normalized sleeping pattern and eliminate possible dysfunction in sleep cycles. Possibly, the most relevant work regarding the regulation of sleep by DSIP has been conducted in the backdrop of insomnia.\u003csup\u003e[9]\u003c\/sup\u003e The results have suggested that the peptide may potentially improve sleep patterns in animal research models. Other studies have further highlighted that it may improve sleep structure and decrease sleep latency in chronic insomnia. However, although polysomnographic studies have suggested that DSIP may induce statistically significant improvement in sleep, sufficient research material is still weak.\u003csup\u003e[10][11]\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eDSIP and Depression\u003c\/strong\u003e\u003cbr\u003eScientists have investigated the role of DSIP in altering mitochondrial activity under hypoxic conditions. The peptide was observed to have the potential to prevent changes in monoamine oxidase type A (MAO-A) and serotonin levels. This finding suggests that the peptide may have an impact on the course of depression.\u003csup\u003e[12]\u003c\/sup\u003e DSIP abundance has been observed to be lower in cerebrospinal fluid of research models of depression compared to the same controls. Sleep and depression are considered to be closely related; a molecule that regulates sleep may likely have action in depressive behavior. However, there has been no scientific approach that aims to balance the DSIP level to date. It has, however, been linked to alterations in the hypothalamic-pituitary-adrenal axis.\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eDSIP and Metabolism\u003c\/strong\u003e\u003cbr\u003eStudies on rat models have highlighted that Delta Sleep-Inducing Peptide may help change stress-related metabolic fluctuations,\u003csup\u003e[13]\u003c\/sup\u003e which may induce mitochondria to switch from oxygen-dependent to oxygen-independent respiration. The latter is considered less efficient and may bring about toxic metabolic byproduct formation. Delta Sleep-Inducing Peptide may promote oxidative phosphorylation even in hypoxic conditions and may thus be impactful in stroke or heart attack. It appears to assist normal metabolic function and thus may reverse the damage caused by oxygen deprivation, protecting tissues until blood flow is restored. Delta Sleep-Inducing Peptide research suggests that DSIP may host anti-oxidant characteristics, potentially preventing free radical formation.\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eDSIP and Withdrawal, Addiction\u003c\/strong\u003e\u003cbr\u003eDSIP research noted improvement in animal research models of withdrawal during ethanol and opiate detoxification. Study findings resulted in 97% and 87% recovery rates for ethanol and opiate withdrawals, respectively. Opiate withdrawal may require DSIP exposure for a longer tenure, as this addiction is considered more resistant to alteration.\u003csup\u003e[6]\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eDSIP and Cancer Cells\u003c\/strong\u003e\u003cbr\u003eResearchers have explored the possibility of mitigating the onset of cancer cell proliferation through exposure to DSIP. Initial research on DSIP has hypothesized that its potential impact on sleep may have downstream impacts as a cancer cell-mitigating agent. This is considered to be possible through sleep-boosted immunity, which may seek out and eliminate rogue cells before they metastasize. Studies have observed that female mice exposed to DSIP for 5 consecutive days of every month starting at the age of 3 months till their death exhibited a 2.6-fold reduction in the development of tumors compared to parallel control groups. There has also been a corresponding 22.6% reduction in the frequency of chromosomal defects in the bone marrow of the DSIP-exposed mice. Research in this area is preliminary, and is still ongoing.\u003csup\u003e[13]\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp class=\"grey-back-d\" style=\"margin-bottom: 30px;\"\u003e\u003cstrong\u003eDSIP and Muscle Cells\u003c\/strong\u003e\u003cbr\u003eDelta Sleep-Inducing Peptide was first discovered in the brains of rabbits during slow-wave sleep and has since been involved with sleep research and central nervous system-mediated control of sleep-wake cycles. Not much is known about DSIP synthesis. High Levels of Delta Sleep-Inducing Peptide present in both CNS tissues and peripheral tissues suggest that the peptide may be produced outside CNS, and its primary function might not be the regulation of sleep. Delta Sleep-Inducing Peptide is also considered a hypothalamic hormone that may influence more than just sleep. In one study, DSIP was suggested to inhibit somatostatin, a protein produced in muscle cells that inhibits muscle growth.\u003csup\u003e[9]\u003c\/sup\u003e By inhibiting somatostatin, DSIP may potentially contribute to hypertrophy and hyperplasia in skeletal muscle. Such direct inhibitory action appears surprising for a peptide thought to be primarily involved in sleep promotion. This has triggered speculation that the peptide might have a larger and more universal role in influencing physiology.\u003cbr\u003e\u003cbr\u003eIn animal models, Delta Sleep-Inducing Peptide has been suggested to regulate blood pressure, heart rate, thermogenesis, and the lymphokine system. Some of these processes appear before any signs of sleep, indicating that Delta Sleep-Inducing Peptide may actually play a role in altering physiology to prepare the organism for sleep onset.\u003c\/p\u003e\n\u003ch3 style=\"color: #555;\"\u003eReferences\u003c\/h3\u003e\n\u003cdiv class=\"white-back-d\" style=\"margin-bottom: 30px;\"\u003e\n\u003col\u003e\n\u003cli\u003eMonnier M, Dudler L, Gächter R, Maier PF, Tobler HJ, Schoenenberger GA. The delta sleep inducing peptide (DSIP). Comparative properties of the original and synthetic nonapeptide. Experientia. 1977 Apr 15;33(4):548-52. . PMID: 862769.\u003c\/li\u003e\n\u003cli\u003eKoval’zon VM. DSIP: peptid sna ili neizvestnyĭ gormon gipotalamusa [DSIP: the sleep peptide or an unknown hypothalamic hormone?]. Zh Evol Biokhim Fiziol. 1994 Mar-Apr;30(2):310-9. Russian. PMID: 7817664.\u003c\/li\u003e\n\u003cli\u003eGrigor'ev VV, Ivanova TA, Kustova EA, Petrova LN, Serkova TP, Bachurin SO. Effects of delta sleep-inducing peptide on pre- and postsynaptic glutamate and postsynaptic GABA receptors in neurons of the cortex, hippocampus, and cerebellum in rats. Bull Exp Biol Med. 2006 Aug;142(2):186-8. English, Russian. doi: 10.1007\/s10517-006-0323-9. PMID: 17369935\u003c\/li\u003e\n\u003cli\u003eSudakov KV, Umriukhin PE, Rayevsky KS. Delta-sleep inducing peptide and neuronal activity after glutamate microiontophoresis: the role of NMDA-receptors. Pathophysiology. 2004 Oct;11(2):81-86.\u003c\/li\u003e\n\u003cli\u003eNakamura A, Nakashima M, Sakai K, Niwa M, Nozaki M, Shiomi H. Delta-sleep-inducing peptide (DSIP) stimulates the release of immunoreactive Met-enkephalin from rat lower brainstem slices in vitro. Brain Res. 1989 Feb 27;481(1):165-8. doi: 10.1016\/0006-8993(89)90498-8. PMID: 2706459.\u003c\/li\u003e\n\u003cli\u003eDick P, Grandjean ME, Tissot R. Successful treatment of withdrawal symptoms with delta sleep-inducing peptide, a neuropeptide with potential agonistic activity on opiate receptors. Neuropsychobiology. 1983;10(4):205-8. doi: 10.1159\/000118012. PMID: 6328354.\u003c\/li\u003e\n\u003cli\u003eGraf MV, Schoenenberger GA. Delta sleep-inducing peptide modulates the stimulation of rat pineal N-acetyltransferase activity by involving the alpha 1-adrenergic receptor. J Neurochem. 1987 Apr;48(4):1252-7. doi: 10.1111\/j.1471-4159.1987.tb05654.x. PMID: 3029331.\u003c\/li\u003e\n\u003cli\u003eNakagaki K, Ebihara S, Usui S, Honda Y, Takahashi Y, Kato N. [Effects of intraventricular injection of anti-DSIP serum on sleep in rats]. Yakubutsu Seishin Kodo. 1986 Jun;6(2):259-65. Japanese. PMID: 3776352.\u003c\/li\u003e\n\u003cli\u003eIyer KS, Marks GA, Kastin AJ, McCann SM. Evidence for a role of delta sleep-inducing peptide in slow-wave sleep and sleep-related growth hormone release in the rat. Proc Natl Acad Sci U S A. 1988 May;85(10):3653-6. . PMID: 3368469; PMCID: PMC280272.\u003c\/li\u003e\n\u003cli\u003eSchneider-Helmert D, Gnirss F, Monnier M, Schenker J, Schoenenberger GA. Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior. Int J Clin Pharmacol Ther Toxicol. 1981 Aug;19(8):341-5. PMID: 6895513.\u003c\/li\u003e\n\u003cli\u003eLarbig W, Gerber WD, Kluck M, Schoenenberger GA. Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic, pronounced pain episodes. A clinical pilot study. Eur Neurol. 1984;23(5):372-85. . PMID: 6548970.\u003c\/li\u003e\n\u003cli\u003eLesch KP, Widerlöv E, Ekman R, Laux G, Schulte HM, Pfüller H, Beckmann H. Delta sleep-inducing peptide response to human corticotropin-releasing hormone (CRH) in major depressive disorder. Comparison with CRH-induced corticotropin and cortisol secretion. Biol Psychiatry. 1988 Jun;24(2):162-72. . PMID: 2839244.\u003c\/li\u003e\n\u003cli\u003eKhvatova EM, Samartzev VN, Zagoskin PP, Prudchenko IA, Mikhaleva II. Delta sleep inducing peptide (DSIP): effect on respiration activity in rat brain mitochondria and stress protective potency under experimental hypoxia. Peptides. 2003 Feb;24(2):307-11. . PMID: 12668217.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"author-details\"\u003e\n\u003cp\u003eDr. Usman (BSc, MBBS, MaRCP) completed his studies in medicine at the Royal College of Physicians, London. He is an avid researcher with more than 30 publications in internationally recognized peer-reviewed journals. Dr. Usman has worked as a researcher and a medical consultant for reputable pharmaceutical companies such as Johnson \u0026amp; Johnson and Sanofi.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"mysite","offers":[{"title":"Default Title","offer_id":51786428907837,"sku":"sku2194756130273","price":100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0997\/4474\/3741\/files\/DSIP-5MG-1-1.webp?v=1780466147"},{"product_id":"ll-37-5mg","title":"(💪Antibacterial) LL-37 (5mg) - 10 Vials","description":"\u003cdiv class=\"et_pb_tab_content\"\u003e\n\u003cdiv class=\"pro-description-con\"\u003e\n\u003cp\u003e🧬 What is LL-37?\u003c\/p\u003e\n\u003cp\u003eLL-37 is a peptide naturally produced by the human body, primarily by:\u003c\/p\u003e\n\u003cp\u003eSkin cells\u003cbr\u003eNeutrophils (white blood cells)\u003cbr\u003eEpithelial tissue\u003c\/p\u003e\n\u003cp\u003eIts core functions are:\u003cbr\u003e🛡️ Antimicrobial + Immune Modulation + Tissue Repair\u003c\/p\u003e\n\u003cp\u003e🔥 Primary Biological Effects\u003cbr\u003e🦠 1️⃣ Antibacterial (Core Function)\u003c\/p\u003e\n\u003cp\u003eLL-37 can directly eliminate:\u003c\/p\u003e\n\u003cp\u003eBacteria 🦠\u003cbr\u003eViruses 🧬\u003cbr\u003eFungi 🍄\u003c\/p\u003e\n\u003cp\u003eBy:\u003cbr\u003e➡️ Destroying the cell membranes of pathogens\u003c\/p\u003e\n\u003cp\u003eIt is classified as a “broad-spectrum natural antibiotic.”\u003c\/p\u003e\n\u003cp\u003e🧠 2️⃣ Immune Modulation\u003c\/p\u003e\n\u003cp\u003eLL-37 does more than just “kill pathogens”; it also modulates the immune system:\u003c\/p\u003e\n\u003cp\u003eRegulates inflammatory responses\u003cbr\u003eAttracts immune cells\u003cbr\u003eControls immune balance\u003c\/p\u003e\n\u003cp\u003eTherefore, it can:\u003cbr\u003e🔥 Act as an anti-inflammatory, or in certain cases, promote inflammatory responses (bidirectional regulation)\u003c\/p\u003e\n\u003cp\u003e🩹 3️⃣ Wound Healing\u003c\/p\u003e\n\u003cp\u003eLL-37 is being studied for:\u003c\/p\u003e\n\u003cp\u003ePromoting skin repair\u003cbr\u003eAccelerating wound healing\u003cbr\u003eStimulating tissue regeneration\u003cbr\u003ePromoting angiogenesis\u003cbr\u003e🧴 Potential in Medicine\/Research\u003c\/p\u003e\n\u003cp\u003eResearch areas include:\u003c\/p\u003e\n\u003cp\u003eChronic wounds (diabetic foot)\u003cbr\u003eSkin infections\u003cbr\u003eEczema \/ Psoriasis\u003cbr\u003eAntibacterial alternatives to antibiotics\u003cbr\u003eRegulation of immune disorders\u003c\/p\u003e\n\u003ch3\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3\u003eLL-37 Peptide\u003c\/h3\u003e\n\u003cp class=\"white-back-d\" style=\"margin-bottom: 30px;\"\u003eLL-37 is a Cathelicidin, a protein family of unique and diverse functions. These peptides, produced by macrophages and polymorphonuclear leukocytes (both types of white blood cells), have been suggested to exhibit bactericidal action. The entire group is classified as antimicrobial peptides (AMPs). The peptide, in particular, has been researched in relation to autoimmune disease, cancer, and wound recovery.\u003csup\u003e[1]\u003c\/sup\u003e For example, researchers note that \u003cem\u003e“Corneal and conjunctival epithelia express LL-37 as part of mucosal innate immunity to protect against bacterial and viral ocular infections.”\u003c\/em\u003e\u003c\/p\u003e\n\u003ch3\u003eSpecifications\u003c\/h3\u003e\n\u003cp class=\"grey-back\"\u003e\u003cstrong\u003eOther Known Titles:\u003c\/strong\u003e CAP-18\u003c\/p\u003e\n\u003cp class=\"white-back\"\u003e\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e C\u003csub\u003e205\u003c\/sub\u003eH\u003csub\u003e340\u003c\/sub\u003eN\u003csub\u003e50\u003c\/sub\u003eO\u003csub\u003e53\u003c\/sub\u003e\u003c\/p\u003e\n\u003cp class=\"grey-back\"\u003e\u003cstrong\u003eMolecular Weight:\u003c\/strong\u003e 4493.34 g\/mol\u003c\/p\u003e\n\u003cp class=\"white-back\" style=\"margin-bottom: 30px;\"\u003e\u003cstrong\u003eSequence:\u003c\/strong\u003e Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-GluLys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-ArgThr-Glu-Ser\u003c\/p\u003e\n\u003ch3\u003eLL-37 Peptide Research\u003c\/h3\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eLL-37 and Inflammatory Disease Models\u003c\/strong\u003e\u003cbr\u003eLL-37, although essentially researched as an antimicrobial peptide, has also been examined in research related to different inflammatory diseases such as lupus, rheumatoid arthritis, psoriasis, and atherosclerosis. LL-37 researchers suggest the peptide’s diverse immune system modulating behaviors based on the type of cells involved and the local inflammatory environment. It has been suggested to reduce apoptotic death of keratinocytes, improve IFN-alpha synthesis, suppress signaling through toll-like receptor 4 (TLR4), modify chemotaxis of neutrophils and eosinophils,\u003csup\u003e[2] \u003c\/sup\u003etrigger IL-18 production, and potentially reduce levels of atherosclerotic plaques. Interestingly, LL-37 (aka CAP-18) appears to stimulate the immune system in a different manner depending on the trigger. Cell culture studies have observed the importance of the inflammatory environment in determining the immune response to LL-37. T-cells appear to improve inflammatory action via LL-37 when not activated but minimize the inflammatory action when activated.\u003cbr\u003e\u003cbr\u003eThe peptide appears to mediate homeostasis of immunological response, thus controlling it from being hyperactive in instances of infection. There appears to be a strong correlation between the peptide levels and the extent of the disease. Initially, CAP-18 was thought to promote autoimmune disorders, but recent results have suggested it may help to abate the damage.\u003csup\u003e[3]\u003c\/sup\u003e The researchers outline that the peptide has a role \u003cem\u003e“in the modulation of immune and inflammatory pathways and their effects on autoimmune and inflammatory diseases.”\u003c\/em\u003e High levels of the peptide may thus help check further increased inflammation.\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eLL-37 and Antimicrobial Characteristics\u003c\/strong\u003e\u003cbr\u003eLL-37 appears to be an important biomolecule of innate immunity and one of the initial proteins to activate during infection. Research findings in skin infection studies suggest that the peptide, though present in limited skin cells, appears to accumulate very fast when invading pathogens are present.\u003csup\u003e[4]\u003c\/sup\u003e It may work with other proteins, like beta-defensin 2, to fight infection. The peptide appears to bind to bacterial lipopolysaccharide (LPS) of the outer membrane of gram-negative bacteria. LPS is considered critical for the membrane integrity of these bacteria. The possible action of LL-37 to bind to and interfere with LPS may make it toxic for certain bacteria. LL-37 may act against gram-positive pathogens, as research on staph infections and other serious bacteria suggested. Research indicates that LL-37 \/ CAP-18 may improve lysozyme’s action, which destroys gram-positive bacteria like\u003cem\u003e Staph aureus.\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eLL-37 may also be heightened and exert antimicrobial actions against nearby potential threats in models of gastrointestinal ulcers, as they report increased peptide expression.\u003csup\u003e[5]\u003c\/sup\u003e This heightened production of LL-37 is likely influenced by the activation of Toll-like receptor 3 (TLR-3). TLR-3 is a type of receptor involved in the immune response, which may be activated by its specific ligand, polyinosinic-polycytidylic acid (poly(I)), a synthetic analog of double-stranded RNA. The interaction with poly(I) may trigger a series of intracellular signaling events that include the involvement of proteins such as Toll\/IL-1 receptor (TIR) domain-containing adaptor-inducing interferon (TRIF), tumor necrosis factor receptor-associated factor 6 (TRAF6), and transforming growth factor β-activated kinase 1 (TAK1). These proteins appear to play crucial roles in immune signaling pathways that might lead to the enhanced expression of LL-37. The peptide's role in the gastrointestinal tract extends to possibly mitigating microbial damage to the gastrointestinal (GI) mucosa via the interactions of the peptide with LPS. Furthermore, the presence of LL-37 may help reduce the secretion of pro-inflammatory cytokines such as interleukin-6 (IL-6) and IL-8, which are significant in the inflammatory response. This reduction is potentially observed in colonic subepithelial myofibroblasts (SEMFs), cells that are part of the connective tissue and may play a role in wound recovery and fibrosis. By moderating the inflammatory response through these interactions, LL-37 might contribute to safeguarding the integrity of the GI tract lining.\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eLL-37 and Lung Disease Models\u003c\/strong\u003e\u003cbr\u003eLPS is found in several different organisms and, in some instances, may become airborne when an environment is contaminated by mold or other fungi. Normal lung tissue responds by producing mucus upon LPS inhalation. Unfortunately, the response is often insufficient to intercept toxic dust syndrome and respiratory diseases like asthma and COPD. LL-37 has been studied in research on toxic dust syndrome.\u003csup\u003e[6]\u003c\/sup\u003e LL-37 appears to promote the proliferation of epithelial cells and the closure of wounds in lung diseases. The peptide may attract airway epithelial cells to injury sites and help vascularization, wound recovery, and supply of nutrition to the newly formed tissue.\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eLL-37 Peptide and Arthritis Models\u003c\/strong\u003e\u003cbr\u003eResearch in murine models observed high LL-37 levels in the joints of rat models of rheumatoid arthritis. Whether the peptide exerts positive or negative actions in such models is unknown. However, several findings indicate the potential of the peptide in inflammation. LL-37 deficiency does not appear to change the outcomes in animal models of arthritis or lupus.\u003csup\u003e[7]\u003c\/sup\u003e Animals expressing the peptide may show the same disease outcome as those lacking the peptide. These results indicate that the physiological reactions in enhanced levels of cathelicidins in arthritis are incidental.\u003cbr\u003e\u003cbr\u003ePeptides derived from LL-37 may reduce collagen damage, which occurs in inflammatory arthritis. Direct exposure of these peptides to arthritic joints in rats was observed to reduce both the severity of the disease and serum levels of antibodies against type II collagen. Direct interleukin-32 (IL-32) involvement in the severity of inflammatory arthritis has been reported. LL-37 and its derivatives may be able to regulate the level of IL-32 response. Researchers consider it reasonable to speculate that the peptide is protective in this disease scenario. Synovial fluid fibroblasts increase toll-like receptor 3 levels, which scientists consider worsens the arthritic condition by increasing inflammatory cytokine expression. LL-37 may interact with TLR4 and either promote pro-inflammatory or anti-inflammatory outcomes.\u003csup\u003e[8]\u003c\/sup\u003e It is yet to be confirmed if LL-37 \/ CAP-18 mediates the same actions against the backdrop of increased TLR3. The peptide has been examined in experimental studies to selectively decrease pro-inflammatory macrophage responses, and researchers suggest its regulation of inflammation to be selective.\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eLL-37 and Intestinal Cancer\u003c\/strong\u003e\u003cbr\u003eCell culture-based research studies have suggested potential multifaceted functions of the peptide in the intestine. The peptide appears to improve the migration of cells necessary for epithelial barrier maintenance of the intestine. LL-37 may reduce apoptosis when there is intestinal inflammation, helping to reduce inflammation's causes and associated pathogenesis. Studies suggest LL-37 pairs with beta-defensin 2 to help in wound recovery. Research indicates that the peptides may work simultaneously to repair and maintain the intestinal epithelium while decreasing TNF-related cell death.\u003csup\u003e[9]\u003c\/sup\u003e Despite being the principal compounds researched in inflammatory bowel conditions, TNF-alpha inhibitors have been reported to exhibit adverse ancillary impacts. LL-37-exposure may potentially reduce the dependence on TNF-alpha inhibitors. Research in the peptide action on cancer cells has generated mixed reports.\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eLL-37 and Blood Vessel Growth\u003c\/strong\u003e\u003cbr\u003eThe peptide appears to produce prostaglandin E2 (PGE2) in endothelial cells, which are cells that line the interior surface of blood vessels.\u003csup\u003e[10]\u003c\/sup\u003e In endothelial cells, PGE2 promotes the development of blood vessels via a process called angiogenesis. It is considered crucial to regulate angiogenesis as it impacts cancer development, stroke outcomes, heart disease, and wound recovery, among others. LL-37 helps to study angiogenesis in-depth to promote it in cardiac disease and discourage cancer milieu. Further research suggests that the peptide appears to support several critical functions of endothelial cells.\u003csup\u003e[11]\u003c\/sup\u003e These functions include cell proliferation, which is the process of cells multiplying; cell migration, which involves the movement of cells from one location to another; and the creation of tube-like structures that resemble small capillaries. Research conducted on mouse models with induced catabolism—where the mouse body breaks down molecules for energy—employed synthetic and natural recombinant versions of LL-37. This research tentatively indicates that exposure to LL-37 may promote the development of new blood vessels and the recovery of epithelial tissues, which include skin and organ linings. Such preliminary findings tentatively support the theory that LL-37 may play a vital role in enhancing wound recovery by possibly influencing the new blood vessel formation process, known as \u003cem\u003evascularization\u003c\/em\u003e.\u003c\/p\u003e\n\u003cp class=\"grey-back-d\" style=\"margin-bottom: 30px;\"\u003e\u003cstrong\u003eLL-37 and Immune Cells\u003c\/strong\u003e\u003cbr\u003eStudies suggest that LL-37 may potentially enhance the immune system's ability to respond to cellular damage.\u003csup\u003e[12]\u003c\/sup\u003e This enhancement might occur through the modulation of the immune system's recognition mechanisms for self-nucleic acids, which include DNA and RNA. It is speculated that this modulation occurs when LL-37 interacts with particular types of cellular receptors, notably scavenger receptors (SRs). These receptors are deemed key in a process known as \u003cem\u003eclathrin-dependent endocytosis\u003c\/em\u003e, which is believed to be crucial for activating inflammatory pathways in cells. In addition, the peptide LL-37 is thought to facilitate the association of double-stranded RNA (dsRNA) with scavenger receptors. This interaction might initiate a cascade of signaling events that ultimately lead to the expression of cytokines, important signaling molecules in the immune response. The study further suggests that the specific interaction between LL-37 and certain scavenger receptors, such as SR-A6 and SR-B1, may be vital. The research also explores the idea that LL-37 might influence the immune system by potentially altering the function of intracellular signaling pathways. These pathways include Toll-like receptors (TLRs) and interferon regulatory factors (IRFs), which are commonly activated in response to foreign nucleic acids. The study posits that through clathrin-mediated endocytosis, LL-37 may facilitate the entry of immune-modulating molecules into cells, an essential step for initiating an immune response. This suggests a sophisticated mechanism by which LL-37 might regulate immune reactions at a cellular level.\u003c\/p\u003e\n\u003ch3 style=\"color: #555;\"\u003eReferences\u003c\/h3\u003e\n\u003cdiv class=\"white-back-d\" style=\"padding-bottom: 5px !important; margin-bottom: 25px !important;\"\u003e\n\u003col style=\"color: #555;\"\u003e\n\u003cli\u003eGordon YJ, Huang LC, Romanowski EG, Yates KA, Proske RJ, McDermott AM. Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr Eye Res. 2005 May;30(5):385-94. . PMID: 16020269; PMCID: PMC1497871.\u003c\/li\u003e\n\u003cli\u003eAlalwani SM, Sierigk J, Herr C, Pinkenburg O, Gallo R, Vogelmeier C, Bals R. The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils. Eur J Immunol. 2010 Apr;40(4):1118-26. . PMID: 20140902; PMCID: PMC2908514.\u003c\/li\u003e\n\u003cli\u003eKahlenberg JM, Kaplan MJ. Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease. J Immunol. 2013 Nov 15;191(10):4895-901. . PMID: 24185823; PMCID: PMC3836506.\u003c\/li\u003e\n\u003cli\u003eReinholz M, Ruzicka T, Schauber J. Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease. Ann Dermatol. 2012 May;24(2):126-35. . Epub 2012 Apr 26. PMID: 22577261; PMCID: PMC3346901.\u003c\/li\u003e\n\u003cli\u003eKusaka; et al. Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease. Clin Exp Immunol. 2018 Jan;19(11). Epub 2017 Sep 28.\u003c\/li\u003e\n\u003cli\u003eGolec M. Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide. Ann Agric Environ Med. 2007;14(1):1-4. PMID: 17655171.\u003c\/li\u003e\n\u003cli\u003eMoreno-Angarita A, Aragón CC, Tobón GJ. Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus. J Transl Autoimmun. 2019 Dec 17;3:100029. . PMID: 32743514; PMCID: PMC7388365.\u003c\/li\u003e\n\u003cli\u003eSingh D, Vaughan R, Kao CC. LL-37 peptide enhancement of signal transduction by Toll-like receptor 3 is regulated by pH: identification of a peptide antagonist of LL-37. J Biol Chem. 2014 Oct 3;289(40):27614-24. . Epub 2014 Aug 4. PMID: 25092290; PMCID: PMC4183800.\u003c\/li\u003e\n\u003cli\u003ePiktel E, Niemirowicz K, Wnorowska U, Wątek M, Wollny T, Głuszek K, Góźdź S, Levental I, Bucki R. The Role of Cathelicidin LL-37 in Cancer Development. Arch Immunol Ther Exp (Warsz). 2016 Feb;64(1):33-46. . Epub 2015 Sep 22. PMID: 26395996; PMCID: PMC4713713.\u003c\/li\u003e\n\u003cli\u003eSalvado MD, Di Gennaro A, Lindbom L, Agerberth B, Haeggström JZ. Cathelicidin LL-37 induces angiogenesis via PGE2-EP3 signaling in endothelial cells, in vivo inhibition by aspirin. Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1965-72. doi: 10.1161\/ATVBAHA.113.301851. Epub 2013 Jun 13. PMID: 23766266.\u003c\/li\u003e\n\u003cli\u003eRamos R, Silva JP, Rodrigues AC, Costa R, Guardão L, Schmitt F, Soares R, Vilanova M, Domingues L, Gama M. Wound healing activity of the human antimicrobial peptide LL37. Peptides. 2011 Jul;32(7):1469-76. doi: 10.1016\/j.peptides.2011.06.005. Epub 2011 Jun 13.\u003c\/li\u003e\n\u003cli\u003eTakahashi, T., Kulkarni, N.N., Lee, E.Y. et al. Cathelicidin promotes inflammation by enabling binding of self-RNA to cell surface scavenger receptors. Sci Rep 8, 4032 (2018).\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"author-details\"\u003e\n\u003ch2\u003e\u003ca href=\"https:\/\/biotechpeptides.com\/dr-marinov\/\"\u003eDr. Usman\u003c\/a\u003e\u003c\/h2\u003e\n\u003cp\u003eDr. Usman (BSc, MBBS, MaRCP) completed his studies in medicine at the Royal College of Physicians, London. He is an avid researcher with more than 30 publications in internationally recognized peer-reviewed journals. Dr. Usman has worked as a researcher and a medical consultant for reputable pharmaceutical companies such as Johnson \u0026amp; Johnson and Sanofi.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"mysite","offers":[{"title":"Default Title","offer_id":51786429071677,"sku":"sku2194756138911","price":300.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0997\/4474\/3741\/files\/LL_37-5MG-1.webp?v=1780466155"},{"product_id":"selank-10mg","title":"(🌴Anxiety relief) Selank Peptide (10mg) - 10 Vials","description":"\u003cdiv class=\"et_pb_tab_content\"\u003e\n\u003cdiv class=\"pro-description-con\"\u003e\n\u003ch3\u003e\n\u003cbr\u003e😌 Anxiety relief\u003cbr\u003e🧠 Emotional stability\u003cbr\u003e🎯 Focus\/cognition\u003cbr\u003e😴 Stress management\u003cbr\u003e🧩 Nootropics\u003c\/h3\u003e\n\u003ch3\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3\u003eSelank Peptide\u003c\/h3\u003e\n\u003cp class=\"white-back-d\" style=\"margin-bottom: 30px;\"\u003eSelank is a small peptide studied for its potential nootropic and behavior-modifying functions in experimental models. It is a synthetic analog of naturally occurring Tuftsin. This immunomodulatory peptide is a short fragment from the immunoglobulin G (IgG), a natural tetrapeptide involved in certain functions that may regulate the immune system. Selank is also posited to possess additional potential for regulating immune cells, IL-6, a wide range of neurotransmitter systems, and brain-derived neurotrophic factor (BDNF).\u003cbr\u003e\u003cbr\u003eSelank differs in structure from the endogenous Tuftsin by an additional three amino acids in its chain, which have been supposed to enhance the metabolic stability and half-life of the synthetic peptide. Specifically, that is the Pro-Gly-Pro segment at the C-terminus of Selank, which might enhance its ability to move through various models, including the blood-brain barrier (BBB). The BBB is a highly selective and semi-permeable barrier that separates circulating blood from the tissues and extracellular fluid of the central nervous system, playing a vital role in regulating substance passage.\u003cbr\u003e\u003cbr\u003eThe inclusion of Pro-Gly-Pro may possibly increase BBB permeability by affecting the peptide's hydrophilicity or lipophilicity, which may enhance its affinity for the BBB's lipid-rich environment. Furthermore, the Pro-Gly-Pro sequence might interact with specific transport mechanisms or receptors at the BBB, possibly initiating facilitated transport or receptor-mediated endocytosis. These processes may enable Selank to circumvent the tight junctions that are said to typically restrict larger molecules.\u003c\/p\u003e\n\u003ch3\u003eSpecifications\u003c\/h3\u003e\n\u003cp class=\"white-back\"\u003e\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e C\u003csub\u003e33\u003c\/sub\u003eH\u003csub\u003e57\u003c\/sub\u003eN\u003csub\u003e11\u003c\/sub\u003eO\u003csub\u003e9\u003c\/sub\u003e\u003c\/p\u003e\n\u003cp class=\"grey-back\"\u003e\u003cstrong\u003eMolecular Weight:\u003c\/strong\u003e 751.88 g\/mol\u003c\/p\u003e\n\u003cp class=\"white-back\" style=\"margin-bottom: 30px;\"\u003e\u003cstrong\u003eSequence:\u003c\/strong\u003e Thr-Lys-Pro-Arg-Pro-Gly-Pro\u003c\/p\u003e\n\u003ch3\u003eSelank Research\u003c\/h3\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eSelank and GABA Neurotransmission\u003c\/strong\u003e\u003cbr\u003eAs per Dr. Anastasiya Volkova of the Institute of Molecular Genetics in Russia, \u003cem\u003e“numerous clinical studies have [suggested] that Selank [may exhibit] strong antianxiety and neuroprotective effects in the [context] of anxiety. Selank and classical antianxiety [compounds] such as benzodiazepine have a similar mode of action. Selank allosterically modulates GABAA receptors and increases the inhibitory action of GABA.”\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eResearchers like Dr. Volkova have suggested that as a result of peptide activity, stress hormone levels may be reduced. Studies conducted by researchers focused on small concentrations of Selank exposure have observed a sedating action similar to benzodiazepines.\u003cbr\u003e\u003cbr\u003eIt has been suggested that the peptide may influence the expression of 7 genes and that it may moderately affect the expression of 45 other targets, all from a set of roughly 84 genes considered to be involved in GABA signaling.\u003csup\u003e[1]\u003c\/sup\u003e Researchers reported that their \u003cem\u003e“results [posited] that Selank caused a number of alterations in the expression of genes involved in neurotransmission.”\u003c\/em\u003e They suggested the peptide may stimulate gene expression in neurons and influence the affinity of GABA receptors for GABA. Synergism between Selank and benzodiazepines and other GABA receptor agonists appears to be mediated through alteration of the receptor affinity.\u003cbr\u003e\u003cbr\u003eResearch in rats observes that Selank and benzodiazepines, when alone, appear to have similar impacts on stress hormones, particularly in models of generalized anxiety. The synergistic potential of these compounds has not been fully explored.\u003csup\u003e[2]\u003c\/sup\u003e The impact of Selank on enkephalin degradation appears to modulate its influence on GABA receptors to a certain extent.\u003cbr\u003e\u003cbr\u003eStudies have suggested enkephalins with shorter blood stability may be present in models of anxiety and phobic disorders. This is apparently caused by increased enkephalinase activity in the blood, which may degrade the enkephalins. Studies in murine models of anxiety posit that the peptide appears to inhibit enkephalinase, stabilize enkephalins, reset the enzymatic pathway, and thus may preserve natural anxiolytic peptides.\u003csup\u003e[3]\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eSelank Peptide and the Immune System\u003c\/strong\u003e\u003cbr\u003eSelank has been studied for its potential to inhibit the gene responsible for the production of the inflammatory cytokine IL-6 in research models of depression but not in control models.\u003csup\u003e[4]\u003c\/sup\u003e Researchers also note that \u003cem\u003e“the adaptogenic properties of selank may be beneficial [in the cases of exposure] to environmental stressors for the prevention of infectious diseases.”\u003c\/em\u003e Selank research suggests that compared to standard anxiolytic compounds, like benzodiazepines, it may improve asthenic symptoms such as fatigue and pain.\u003csup\u003e[5]\u003c\/sup\u003e This may be due to the peptide’s apparent stabilization of enkephalins and potential ability to modify the expression of IL-6. The peptide appears to affect the expression of nearly 34 genes in the inflammatory pathway, which may include those affecting chemokines, cytokines, and receptors. Specifically, it has been studied in relation to Bcl6 expression, which is considered to promote immune development.\u003cbr\u003e\u003cbr\u003eThis scientific study not only helps explore the complex potential impact of the peptide. It may also improve our understanding of immune systems in general. Selank and its truncated versions may mediate transient gene expression for C3, CAsp1, Il2rf, and Xcr1 in the mouse spleen. Selank may alter the immune system's balance and thereby modulate inflammation.\u003csup\u003e[6]\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eSelank Peptide and Metabolic Actions on Lipid Metabolism\u003c\/strong\u003e\u003cbr\u003eSelank has been researched and compared to a placebo regarding its potential action on lipid metabolism in murine models of obesity.\u003csup\u003e[7]\u003c\/sup\u003e The analysis suggests that the group exposed to Selank appeared to exhibit reductions in cholesterol and fat levels, ranging approximately between 25% and 58%. This implies that Selank may potentially decrease specific forms of lipids, such as low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL) cholesterol, and triglycerides. This observation suggests that Selank might have a role, whether direct or indirect, in influencing lipid metabolism mechanisms and might exhibit hypocholesterolemic (cholesterol-lowering) and hypolipidemic (lipid-lowering) properties.\u003cbr\u003e\u003cbr\u003eFurther, the research indicated notable improvements in hemostasis-related parameters, including increased total fibrinolytic activity and reduced platelet aggregation. These changes might imply potential benefits in conditions that predispose to clot formation. Additionally, Selank's potential modulatory action on glucose homeostasis was suggested, indicating it might help maintain stable blood glucose levels. The study also reported an enhancement in the fat metabolism rate within the Selank group, which eventually aligned with the metabolism rate observed in control models. Weight measurements showed that the test group of research models had an average weight gain of 40g during the study period. In contrast, the Selank group maintained their weight throughout the study, with a gradual reduction observed upon peptide exposure.\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eSelank Peptide and Nootropic Actions\u003c\/strong\u003e\u003cbr\u003eAnxiety and learning\/memory have shown a strong inverse association in studies conducted on test models by researchers. The peptide appears to potentially reduce the impact of anxiety on cognitive function. Selank research has suggested that the peptide may improve memory traceability and recall in rats.\u003csup\u003e[8]\u003c\/sup\u003e This improvement was independent of the anxiety levels of the rats. The peptide appears to trigger better memory recall through the hippocampal expression of 36 different genes.\u003cbr\u003e\u003cbr\u003eThe majority of the targets are membrane-associated proteins that regulate ion movement across cell membranes. Thus, the ion-dependent processes in learning and memory appear to be enhanced by the molecule. Selank researchers have posited its potential to help in formation and access of memories. It may also help to rescue memory and cognitive abilities after injury in rats exposed to neurotoxins. This inference is considered to be due to the apparent inhibition of catecholamines in the brain.\u003csup\u003e[9]\u003c\/sup\u003e Selank may thereby play a hand in the restoration of cognitive function after an injury.\u003cbr\u003e\u003cbr\u003eAnother study also investigated the potential nootropic actions of the synthetic peptide Selank in murine models with both normal and reduced learning abilities. Results in normal murine models suggested that Selank potentially enhanced the learning process, particularly notable by the third day of repeated exposure. The number of correct avoidance responses increased, and the number of errors decreased. This action was observed to persist, suggesting an improvement in memory retention.\u003cbr\u003e\u003cbr\u003eNotably, Selank's influence seemed to commence during the consolidation phase of learning. In models with initially reduced learning ability, Selank exhibited a rapid potential impact, with improvements observed from the first experimentation day. Researchers observed this group and indicated a progressive increase in correct responses and a decrease in errors across the training period. The data suggests that Selank might play a role in optimizing learning and memory processes by possibly enhancing the formation and consolidation of conditioned reflexes.[10]\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eSelank and Serotonin Neurotransmission\u003c\/strong\u003e\u003cbr\u003eResearch suggests that Selank might have the capability to interact with serotonin signaling pathways.\u003csup\u003e[12]\u003c\/sup\u003e Serotonin signaling is thought to play a role in regulating mood and anxiety in the brain. Studies using murine models with inhibited serotonin synthesis imply that Selank may contribute to the modulation of serotonin levels when serotonergic function is impaired.\u003cbr\u003e\u003cbr\u003eIt is hypothesized that Selank may enhance serotonin metabolism in the brainstem, inducing a potentially quick action on the serotonin system. The peptide is believed to potentially increase serotonin metabolic activity in brain regions involved in mood and anxiety regulation. Moreover, the study hypothesizes that Selank's ability to boost serotonin metabolism might provide a mechanism for addressing disturbances linked to reduced serotonin function.\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eSelank and Neurotrophic Factors\u003c\/strong\u003e\u003cbr\u003eSelank might influence the expression of brain-derived neurotrophic factor (BDNF), a protein considered essential for the survival and growth of neurons in the brain.\u003csup\u003e[13]\u003c\/sup\u003e Some studies suggest that Selank may potentially elevate the levels of BDNF mRNA in the hippocampus, a brain region associated with memory formation and emotional regulation. This potential ability of Selank to enhance BDNF expression, especially in scenarios where stress and glucocorticoids may suppress BDNF levels, implies its potential importance in research exploring neuroplasticity.\u003c\/p\u003e\n\u003cp class=\"white-back-d\" style=\"margin-bottom: 30px;\"\u003e\u003cstrong\u003eSelank Peptide and Nociception\u003c\/strong\u003e\u003cbr\u003eEnkephalins are natural peptides that are considered to reduce the severity of nociception by interacting with opioid receptors. Research suggests that Selank might potentially inhibit enkephalin-degrading enzymes, which are deemed responsible for breaking down enkephalins.\u003csup\u003e[11]\u003c\/sup\u003e Enkephalins are naturally occurring ligands that bind to opioid receptors and are believed to be involved in regulating pain, mood, and stress responses. By possibly inhibiting these enzymes, Selank may slow the degradation of enkephalins, potentially increasing their availability and enhancing their actions.\u003cbr\u003e\u003cbr\u003eAdditionally, the research data indicated that Selank exposure might lead to an increase in the half-life (tau(1\/2)) of leu-enkephalin, a specific type of enkephalin, particularly in models of anxiety. This implies that Selank may prolong the presence of leu-enkephalin in the system, which might contribute to its anxiolytic actions. However, these findings still need to be investigated, and the precise mechanisms and extent of Selank's impact still needs to be fully understood.\u003csup\u003e[5] \u003c\/sup\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3 style=\"color: #555;\"\u003eReferences\u003c\/h3\u003e\n\u003cdiv class=\"white-back-d\" style=\"margin-bottom: 30px;\"\u003e\n\u003col style=\"color: #555;\"\u003e\n\u003cli\u003eVolkova A, Shadrina M, Kolomin T, Andreeva L, Limborska S, Myasoedov N, Slominsky P. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Front Pharmacol. 2016 Feb 18;7:31. . PMID: 26924987; PMCID: PMC4757669.\u003c\/li\u003e\n\u003cli\u003eKasian A, Kolomin T, Andreeva L, Bondarenko E, Myasoedov N, Slominsky P, Shadrina M. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behav Neurol. 2017;2017:5091027. . Epub 2017 Feb 9. PMID: 28280289; PMCID: PMC5322660.\u003c\/li\u003e\n\u003cli\u003eSokolov OY, Meshavkin VK, Kost NV, Zozulya AA. Effects of Selank on behavioral reactions and activities of plasma enkephalin-degrading enzymes in mice with different phenotypes of emotional and stress reactions. Bull Exp Biol Med. 2002 Feb;133(2):133-5. . PMID: 12432865.\u003c\/li\u003e\n\u003cli\u003eUchakina ON, Uchakin PN, Miasoedov NF, Andreeva LA, Shcherbenko VE, Mezentseva MV, Gabaeva MV, Sokolov OIu, Zozulia AA, Ershov FI. [Immunomodulatory effects of selank in patients with anxiety-asthenic disorders]. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(5):71-5. Russian. PMID: 18577961.\u003c\/li\u003e\n\u003cli\u003eZozulia AA, Neznamov GG, Siuniakov TS, Kost NV, Gabaeva MV, Sokolov OIu, Serebriakova EV, Siranchieva OA, Andriushenko AV, Telesheva ES, Siuniakov SA, Smulevich AB, Miasoedov NF, Seredenin SB. [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia]. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38-48. Russian. PMID: 18454096.\u003c\/li\u003e\n\u003cli\u003eAgapova TIu, Agniullin IaV, Silachev DN, Shadrina MI, Slominskiĭ PA, Shram SI, Limborskaia SA, Miasoedov NF. [Effect of semax on the temporary dynamics of brain-derived neurotrophic factor and nerve growth factor gene expression in the rat hippocampus and frontal cortex]. Mol Gen Mikrobiol Virusol. 2008;(3):28-32. Russian. PMID: 18756821.\u003c\/li\u003e\n\u003cli\u003eN.F. Mjasoedov et al, The Influence of Selank on the Parameters of the Hemostasis System, Lipid Profile, and Blood Sugar Level in the Course of Experimental Metabolic Syndrome. April 14, 2014.\u003c\/li\u003e\n\u003cli\u003eSemenova TP, Kozlovskiĭ II, Zakharova NM, Kozlovskaia MM. [Experimental optimization of learning and memory processes by selank]. Eksp Klin Farmakol. 2010 Aug;73(8):2-5. Russian. PMID: 20919548.\u003c\/li\u003e\n\u003cli\u003eSemenova TP, Kozlovskaya MM, Zakharova NM, Kozlovskii II, Zuikov AV. Effect of selank on cognitive processes after damage inflicted to the cerebral catecholamine system during early ontogeny. Bull Exp Biol Med. 2007 Nov;144(5):689-91. . PMID: 18683497.\u003c\/li\u003e\n\u003cli\u003eKozlovskii II, Danchev ND. The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats. Neurosci Behav Physiol. 2003 Sep;33(7):639-43.\u003c\/li\u003e\n\u003cli\u003eKost, N. V., Sokolov, O. I.u, Gabaeva, M. V., Grivennikov, I. A., Andreeva, L. A., Miasoedov, N. F., \u0026amp; Zozulia, A. A. (2001). Ingibiruiushchee deĭstvie semaksa i selanka na énkefalindegradiruiushchie fermenty syvorotki krovi cheloveka [Semax and selank inhibit the enkephalin-degrading enzymes from human serum]]. Bioorganicheskaia khimiia, 27(3), 180–183.\u003c\/li\u003e\n\u003cli\u003eSemenova TP, kozlovskiĭ II, Zakharova NM, Kozlovskaia MM. [Comparison of the effects of selank and tuftsin on the metabolism of serotonin in the brain of rats pretreated with PCPA]. Eksp Klin Farmakol. 2009 Jul-Aug;72(4):6-8. Russian. PMID: 19803361.\u003c\/li\u003e\n\u003cli\u003eInozemtseva, L. S., Karpenko, E. A., Dolotov, O. V., Levitskaya, N. G., Kamensky, A. A., Andreeva, L. A., \u0026amp; Grivennikov, I. A. (2008). Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 421, 241–243.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"author-details\"\u003e\n\u003cp\u003eDr. Usman (BSc, MBBS, MaRCP) completed his studies in medicine at the Royal College of Physicians, London. He is an avid researcher with more than 30 publications in internationally recognized peer-reviewed journals. Dr. Usman has worked as a researcher and a medical consultant for reputable pharmaceutical companies such as Johnson \u0026amp; Johnson and Sanofi.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"mysite","offers":[{"title":"Default Title","offer_id":51786429104445,"sku":"sku2194756146315","price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0997\/4474\/3741\/files\/Selank-10MG-2-1.webp?v=1780466157"},{"product_id":"pt-141-10mg-bremelanotide","title":"（❤️Sexual desire） PT-141 (Bremelanotide) Peptide (10mg) -10 Vials","description":"\u003cdiv class=\"et_pb_tab_content\"\u003e\n\u003cdiv class=\"pro-description-con\"\u003e\n\u003ch4\u003ePT-141 (Bremelanotide) is a peptide primarily associated with libido and sexual arousal.\u003cbr\u003eUnlike many fitness peptides, it acts on:\u003cbr\u003e🧠 the central nervous system (specifically melanocortin receptors),\u003cbr\u003erather than directly affecting blood vessels or hormones.\u003c\/h4\u003e\n\u003ch4\u003eIts most well-known approved pharmaceutical version is:\u003cbr\u003eVyleesi\u003c\/h4\u003e\n\u003ch4\u003eThis is an FDA-approved prescription medication for:\u003c\/h4\u003e\n\u003ch4\u003etreating Hypoactive Sexual Desire Disorder (HSDD) in certain women.\u003c\/h4\u003e\n\u003ch3\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3\u003ePT-141 (Bremelanotide) Peptide\u003c\/h3\u003e\n\u003cp class=\"white-back-d\" style=\"margin-bottom: 30px;\"\u003ePT-141, also known as Bremelanotide, was derived from a synthetic melanocortin analog known as Melanotan 2 (MT-2). A melanocortin analog, such as PT-141 and MT-2, is considered to be any synthetic compound designed to mimic or influence the functions of natural melanocortin peptides. These peptides, such as the alpha-melanocyte stimulating hormone (α-MSH), may be involved in a range of physiological processes including appetite regulation, energy homeostasis, immune responses, and skin cell pigmentation. PT-141 is a melanocortin analog that was developed to interact with Melanocortin-4 Receptor (MC-4R). It has been studied for a variety of potential characteristics and bioactivities through its interaction with this receptor. Apart from MC-4R, there are other melanocortin receptors like MC-1R, MC-2R, MC-3R, and MC-5R, each associated with different potential functions. For instance, MC-1R may be primarily involved in skin cell and hair follicle pigmentation, MC-2R appears to play a crucial role in the adrenal axis and stress response, MC-3R is implicated in the regulation of energy homeostasis, and MC-5R has been linked to exocrine function and thus impacts processes such as sweating and sebum production.\u003c\/p\u003e\n\u003ch3\u003eSpecifications\u003c\/h3\u003e\n\u003cp class=\"grey-back\"\u003e\u003cstrong\u003eOther Known Titles:\u003c\/strong\u003e Bremelanotide\u003c\/p\u003e\n\u003cp class=\"white-back\"\u003e\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e C\u003csub\u003e50\u003c\/sub\u003eH\u003csub\u003e68\u003c\/sub\u003eN\u003csub\u003e14\u003c\/sub\u003eO\u003csub\u003e10\u003c\/sub\u003e\u003c\/p\u003e\n\u003cp class=\"grey-back\"\u003e\u003cstrong\u003eMolecular Weight:\u003c\/strong\u003e 1025.18 g\/mol\u003c\/p\u003e\n\u003cp class=\"white-back\" style=\"margin-bottom: 30px;\"\u003e\u003cstrong\u003eSequence:\u003c\/strong\u003e Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1)-OH\u003c\/p\u003e\n\u003ch3\u003ePT-141 Peptide Research\u003c\/h3\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003ePT-141 Peptide (Bremelanotide) and the Melanocortin-4 Receptors\u003c\/strong\u003e\u003cbr\u003ePT-141 appears to uniquely stimulate the MC-4R, which may trigger cascades in the central nervous system which impact the brain region that controls reproductive and copulatory behavior.\u003csup\u003e[1]\u003c\/sup\u003e The researchers suggest that \u003cem\u003e“The erectogenic potential of PT-141, its tolerability profile and its [potential] to cause significant erections in [cases that otherwise] do not have an adequate response to a PDE5 inhibitor suggest that PT-141 may provide an alternative [avenue for ED research].”\u003c\/em\u003e Studies in mice agonist binding to MC-4R reported sexual arousal and increased copulation activity in both males and females.\u003csup\u003e[2]\u003c\/sup\u003e The mechanism of PT-141 appears to be different from compounds that manage blood flow to the genitals.\u003csup\u003e[3][4]\u003c\/sup\u003e Researchers suggest that MC-4R agonism, potentially combined with existing modalities, may encourage both physiological and psychological alterations. In a meticulously designed study, researchers conducted a randomized, double-blinded, placebo-controlled, crossover clinical trial to explore the potential stimulation of the Melanocortin-4 receptor on neural pathways involved in sexual processing. Initial findings suggest that PT-141 as an agonist may potentially enhance sexual desire for a duration up to 24 hours, in comparison to a placebo. During the functional neuroimaging segment of the study, there was an apparent increase in activity observed in the cerebellar and supplementary motor areas. These regions are deemed crucial for motor control and planning. Conversely, there was a possible reduction in activation within the secondary somatosensory cortex, an area involved in processing sensory information, specifically when under the influence of visual stimuli, differing from responses observed with the placebo. Additionally, it was theorized that MC-4R agonists like PT-141 might enhance the functional connectivity between the amygdala, a key region in emotion regulation, and the insula, which is involved in perception and emotional responses, during exposure to the stimuli. This was in contrast to the actions noted with the placebo. These preliminary observations led researchers to suggest that MC-4R agonists could potentially enhance the neural processing associated with sexual arousal and behavior.\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003ePT-141 Peptide (Bremelanotide) and Cavernous Tissues\u003c\/strong\u003e\u003cbr\u003eDespite suggestions that the mechanism of PT-141 appears to be different from compounds that manage blood flow to the genitals, some scholars propose that compounds classified as melanocortin agonists, such as PT-141, might exhibit properties conducive to inducing erections by influencing the concentrations of vasodilators within specific tissues.\u003csup\u003e[5]\u003c\/sup\u003e Research has explored the possible involvement of the nitric oxide (NO)-cyclic guanosine monophosphate (cyclic GMP) pathway in the action of melanocortin agonists on erectile function. This pathway is posited as pivotal in many processes, including the regulation of vascular tone and blood flow within cavernosal tissues. One particular study investigated this by conducting experiments where the pudendal nerves, which are considered vital for erectile function, were bilaterally transected, and nitric oxide synthase (the enzyme responsible for producing NO) was blocked using a specific inhibitor known as L-NAME.\u003csup\u003e[5]\u003c\/sup\u003e The findings from these experiments suggested that disrupting the pudendal nerves or inhibiting nitric oxide synthesis might potentially diminish the Melanocortin-agonist-induced increases in pressure within cavernosal tissues, observed in anesthetized mouse models. These tissues are deemed key structures involved in achieving an erection due to their role in trapping blood within the cavernosal tissues. Consequently, the data cautiously suggest that activating central melanocortin receptors with melanocortin agonists like PT-141 may lead to enhanced cavernosal pressure, presumably through the enhanced release of NO by neurons, although this mechanism remains speculative and requires further confirmation.\u003c\/p\u003e\n\u003cp class=\"white-back-d\" style=\"margin-bottom: 30px;\"\u003e\u003cstrong\u003ePT-141 Peptide (Bremelanotide) and Cell Survival\u003c\/strong\u003e\u003cbr\u003eThe MC-1R receptor may be an important stimulus of DNA repair pathways, and is of relevance in cell survival.\u003csup\u003e[6]\u003c\/sup\u003e The scientists reported that \u003cem\u003e“MC1R signalling activates antioxidant, DNA repair and survival pathways.”\u003c\/em\u003e PT-141 retains some MC-1R activity, despite being biased towards MC-3Rs and MC-4Rs.\u003c\/p\u003e\n\u003ch3 style=\"color: #555;\"\u003eReferences\u003c\/h3\u003e\n\u003cdiv class=\"white-back-d\" style=\"margin-bottom: 30px;\"\u003e\n\u003col style=\"color: #555;\"\u003e\n\u003cli\u003eRosen RC, Diamond LE, Earle DC, Shadiack AM, Molinoff PB. Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra. Int J Impot Res. 2004 Apr;16(2):135-42.\u003c\/li\u003e\n\u003cli\u003eRössler AS, Pfaus JG, Kia HK, Bernabé J, Alexandre L, Giuliano F. The melanocortin agonist, melanotan II, enhances proceptive sexual behaviors in the female rat. Pharmacol Biochem Behav. 2006 Nov;85(3):514-21. . Epub 2006 Nov 20. PMID: 17113634.\u003c\/li\u003e\n\u003cli\u003eClayton AH, Althof SE, Kingsberg S, DeRogatis LR, Kroll R, Goldstein I, Kaminetsky J, Spana C, Lucas J, Jordan R, Portman DJ. Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial. Womens Health (Lond). 2016 Jun;12(3):325-37. . Epub 2016 May 16. PMID: 27181790; PMCID: PMC5384512.\u003c\/li\u003e\n\u003cli\u003eMiller MK, Smith JR, Norman JJ, Clayton AH. Expert opinion on existing and developing drugs to treat female sexual dysfunction. Expert Opin Emerg Drugs. 2018 Sep;23(3):223-230. . Epub 2018 Oct 11. PMID: 30251897.\u003c\/li\u003e\n\u003cli\u003ePfaus, J. G., Shadiack, A., Van Soest, T., Tse, M., \u0026amp; Molinoff, P. (2004). Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist. Proceedings of the National Academy of Sciences of the United States of America, 101(27), 10201–10204.\u003c\/li\u003e\n\u003cli\u003eMaresca V, Flori E, Picardo M. Skin phototype: a new perspective. Pigment Cell Melanoma Res. 2015 Jul;28(4):378-89. . Epub 2015 Apr 11. PMID: 25786343.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"author-details\"\u003e\n\u003cp\u003eDr. Usman (BSc, MBBS, MaRCP) completed his studies in medicine at the Royal College of Physicians, London. He is an avid researcher with more than 30 publications in internationally recognized peer-reviewed journals. Dr. Usman has worked as a researcher and a medical consultant for reputable pharmaceutical companies such as Johnson \u0026amp; Johnson and Sanofi.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"mysite","offers":[{"title":"Default Title","offer_id":51786429890877,"sku":"sku2194756145081","price":140.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0997\/4474\/3741\/files\/PT-141-10MG-1.webp?v=1780466170"},{"product_id":"bpc-157","title":"（💪Repair + Anti-inflammatory + Tissue Regeneration） BPC-157 (5mg) - Biotech Peptides","description":"\u003cdiv class=\"et_pb_tab_content\"\u003e\n\u003cdiv class=\"pro-description-con\"\u003e\n\u003cp\u003e🧬 What is BPC-157?\u003c\/p\u003e\n\u003cp\u003eBPC-157 is a synthetic peptide derived from a fragment of gastric mucin and is classified as a “protective\/repair peptide.”\u003c\/p\u003e\n\u003cp\u003eIt is not:\u003c\/p\u003e\n\u003cp\u003e❌ A muscle-building agent (like IGF-1)\u003cbr\u003e❌ A GH stimulator (like CJC \/ Ipamorelin)\u003c\/p\u003e\n\u003cp\u003eInstead, it falls under:\u003cbr\u003e👉 Repair + Anti-inflammatory + Tissue Regeneration\u003c\/p\u003e\n\u003cp\u003e🩹 Core Effects (Research + Experience)\u003cbr\u003e🔥 1️⃣ Tissue Repair (Core Effect)\u003c\/p\u003e\n\u003cp\u003eBPC-157 has been studied for:\u003c\/p\u003e\n\u003cp\u003eMuscle strains\u003cbr\u003eLigament injuries\u003cbr\u003eTendinitis\u003cbr\u003eJoint soft tissue injuries\u003c\/p\u003e\n\u003cp\u003e👉 In the fitness community, it’s often called:\u003cbr\u003e“injury recovery peptide”\u003c\/p\u003e\n\u003cp\u003e🧠 2️⃣ Nerve and Vascular Repair (Research Focus)\u003c\/p\u003e\n\u003cp\u003eSome animal studies suggest it may:\u003c\/p\u003e\n\u003cp\u003ePromote angiogenesis\u003cbr\u003ePromote nerve repair\u003cbr\u003eAccelerate soft tissue healing\u003cbr\u003e🧴 3️⃣ Gastrointestinal Protection (Original Source)\u003c\/p\u003e\n\u003cp\u003eOne of BPC’s sources and functions is:\u003c\/p\u003e\n\u003cp\u003eGastric mucosal protection\u003cbr\u003eGastric ulcer repair\u003cbr\u003eRegulation of intestinal inflammation\u003c\/p\u003e\n\u003cp\u003eSo some people also use it for:\u003c\/p\u003e\n\u003cp\u003eIBS (Irritable Bowel Syndrome)\u003cbr\u003eGastritis-related issues (research\/anecdotal)\u003cbr\u003e💪 Why the fitness community loves it so much\u003c\/p\u003e\n\u003cp\u003eBecause it addresses a core issue:\u003c\/p\u003e\n\u003cp\u003e👉 “Slow recovery from training injuries”\u003c\/p\u003e\n\u003cp\u003eCommon uses discussed:\u003c\/p\u003e\n\u003cp\u003eRotator cuff injuries\u003cbr\u003eElbow inflammation (tennis elbow)\u003cbr\u003eKnee soft tissue issues\u003cbr\u003eRecovery from strains\u003c\/p\u003e\n\u003cp\u003eMany people say:\u003cbr\u003e➡️ Recovery speed is “noticeably faster”\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eBPC-157 Peptide\u003c\/h3\u003e\n\u003cp class=\"white-back-d\" style=\"margin-bottom: 30px;\"\u003eBPC-157, Body Protection Compound-157, is obtained from the parent protein Body Protection Compound (BPC). BPC is a naturally occurring protein in the digestive tract.\u003csup\u003e[1]\u003c\/sup\u003e BPC -57 is a penta-decapeptide made up of 15 amino acids, and is derived from a stretch of endogenous BPC identified and isolated from gastric juice. Animal studies have suggested its potential in supporting tissue repair processes in muscle, tendon, and torn ligaments. It may further protect organs and potentially prevent gastric ulcer development.\u003csup\u003e[2] \u003c\/sup\u003eSikiric et al. noted that there was \"\u003cem\u003ea strong protection, noted following [exposure to] BPC 157.\" \u003c\/em\u003e BPC-157 also has the potential to enhance the function of the digestive tract and prevent against irritable bowel syndrome (IBS), gastrointestinal cramps, and Crohn’s disease. The peptide also has possible analgesic characteristics.\u003c\/p\u003e\n\u003ch3\u003eSpecifications\u003c\/h3\u003e\n\u003cp class=\"white-back\"\u003e\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e C\u003csub\u003e62\u003c\/sub\u003eH\u003csub\u003e98\u003c\/sub\u003eN\u003csub\u003e16\u003c\/sub\u003eO\u003csub\u003e22\u003c\/sub\u003e\u003c\/p\u003e\n\u003cp class=\"grey-back\"\u003e\u003cstrong\u003eMolecular Weight:\u003c\/strong\u003e 1419.556 g\/mol\u003c\/p\u003e\n\u003cp class=\"white-back\" style=\"margin-bottom: 30px;\"\u003e\u003cstrong\u003eSequence:\u003c\/strong\u003e L-Valine,glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-Lprolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglycyl-L-leucyl-;glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyllysyl-L-prolyl-L-alanyl-L- alpha-aspartylL-alpha-aspartyl-L-alanylglycyl-L-leucyl-L-valine\u003c\/p\u003e\n\u003ch3\u003eBPC-157 Peptide Research\u003c\/h3\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eBPC-157 and Wound Healing\u003c\/strong\u003e\u003cbr\u003eThe GI tract's mucosal barrier is considered to protect the underlying tissues from the harmful actions of bile, gastric acid, and other compounds necessary for the digestion and absorption of nutrients from food. BPC-157 is believed to help preserve the structural integrity of the mucosal layer. The role appears to be partially mediated through the recruitment of fibroblasts. Fibroblasts are considered to produce extracellular matrix proteins such as fibrin, collagen, elastin, and others. BPC-157 has been suggested to promote the proliferation and faster migration of fibroblasts in a concentration-dependent manner.\u003csup\u003e[3]\u003c\/sup\u003e In another research study it was hypothesized that BPC-157 may have led to an acceleration in wound closure compared to the control group via an improvement in the formation of granulation tissue, reepithelialization, dermal remodeling, and collagen deposition. There is a possibility that BPC-157 may have promoted the expression of vascular endothelial growth factor (VEGF) in the injured skin tissues.\u003csup\u003e[4]\u003c\/sup\u003e Moreover, the researchers commented that BPC-157 may have shown a potential to enhance umbilical vein endothelial cell proliferation (HUVECs). Furthermore, there may have been a significant increase in the migration of HUVECs, as indicated by the comments from wound healing assays. BPC-157 possibly resulted in an upregulation of VEGF-a expression and acceleration of vascular tube formation. It also appeared that BPC-157 may have regulated the phosphorylation level of extracellular signal-regulated kinases 1 and 2 (ERK1\/2) and their downstream targets, including c-Fos, c-Jun, and Egr-1. These molecules are hypothesized to potentially play significant roles in cell growth, migration, and angiogenesis.\u003csup\u003e[4]\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eBPC-157 and Vascular Growth and Collateralization\u003c\/strong\u003e\u003cbr\u003eThe peptide has the potential as an angiogenic, and studies suggest it may enhance endothelial cells’ growth and proliferation, which line the walls of blood vessels. Research in rats has observed that the peptide may substantially increase the collateral blood vessel growth rate in the setting of ischemia.\u003csup\u003e[5]\u003c\/sup\u003e That action has been primarily observed in the GI tract, but research has noted similar observations in muscle, neurological, and cardiovascular tissues. Research using chicken embryos has posited that BPC-157 may also have the potential to promote vascular growth through activation of VEGFR2 pathway. VEGFR2 is a cell surface receptor active in nitric oxide signaling and is considered to support cell activity and proliferation. BPC-157 may promote vascular “running” in cultured cells. This is the growth and development of new blood vessels towards a site of injury or around the area of blood clot to reach out to distal tissues and thus protect cellular function.\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eBPC-157 and Tendon Healing\u003c\/strong\u003e\u003cbr\u003eBPC-157 studies have observed potential in connective tissue healing such as ligament, bone, and tendon. Ligament and tendon injuries take a long time to heal due to the poor blood supply to these tissues. There is slower migration of fibroblasts and wound-healing cells to these sites of injury owing to the poor blood supply, and therefore the repair process is obstructed. The peptide has the potential to improve the collateralization and density of fibroblasts in the sites of injury in research involving rat tendons.\u003csup\u003e[6]\u003c\/sup\u003e More specifically, the study also hypothesized that BPC-157 might accelerate the outgrowth of tendon fibroblasts from tendon explants. This suggests that BPC-157 may potentially promote the growth of new cells in the injured tendon. Further, the survival of the cells to which BPC-157 was applied may be significantly increased when exposed to H(2)O(2) stress, indicating a potential protective action against oxidative stress. BPC-157 may also enhance the migration of tendon fibroblasts, as indicated by the transwell filter migration assay used in the study. This may imply that BPC-157 potentially promotes the movement of tendon fibroblasts. Moreover, BPC-157 may accelerate the spreading of tendon fibroblasts on culture dishes, suggesting potentially increased cell adhesion and attachment.\u003csup\u003e[6] \u003c\/sup\u003eThis experimental research has suggested BPC-157 to be a positive impactor in comparison to EFG, bFGF, and VGF hormones. Immunostaining assays involving FITC conjugated phalloidin have suggested BPC-157 to enhance F-actin formation in fibroblasts. F-actin is considered to be crucial for cell structure and function and promotes cell migration. Immunoblotting experiments have noted that BPC-157 appears to increase the phosphorylation of paxillin and FAK proteins, which are considered crucial for cellular migration. More specifically, BPC-157 may induce F-actin formation in tendon fibroblasts, potentially indicating enhanced cytoskeletal organization and cell motility. Further analysis using Western blotting indicates that BPC-157 may activate the FAK (focal adhesion kinase) and paxillin proteins. The phosphorylation levels of FAK and paxillin may increase with BPC-157, while the total amounts of these proteins may remain unchanged. This potentially suggests that BPC-157 may activate the FAK-paxillin pathway, which may be involved in the promotion of tendon fibroblast migration and cell adhesion.\u003csup\u003e[6]\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eBPC-157 and Antioxidant Characteristics\u003c\/strong\u003e\u003cbr\u003eStudies in rat models have proposed that BPC-157 may exhibit antioxidant characteristics, and may help to neutralize oxidative stress molecules like nitric oxide and malondialdehyde (MDA) and reactive oxygen species in the GI tract.\u003csup\u003e[7]\u003c\/sup\u003e Research further hypothesized that modified Lactococcus lactis bacteria may increase the amount of the peptide in cell culture and can possibly deliver it to the GI tract.\u003cbr\u003eAnother study aimed to evaluate early functional recovery and inflammation in tendon cells after the application of BPC-157.\u003csup\u003e[8]\u003c\/sup\u003e. The researchers utilized the Achilles functional index (AFI), myeloperoxidase activity, histological inflammatory cell influx, and vascular index as potential markers. The results suggest that BPC-157 may have improved functional recovery, as indicated by a potential increase in AFI values at all time points. This improvement was hypothesized to be attributed to its purported anti-inflammatory action, including a potential decrease in myeloperoxidase (MPO) activity and histological inflammatory cell influx. Furthermore, BPC-157 potentially increased the formation of new blood vessels, as inferred by a possible increase in the vascular index. On the other hand, methylprednisolone also possibly decreased MPO activity and histological inflammatory cell influx, suggesting its potential anti-inflammatory action. However, methylprednisolone hypothetically decreased the formation of new blood vessels and may not have significantly affected early functional recovery.\u003csup\u003e[8] \u003c\/sup\u003eAnother study examined the proposed action of a pentadecapeptide BPC-157 on inflammation and bone resorption in experimental periodontitis. Inflammation was assessed using the Evans blue plasma extravasation technique and histology. Evans blue extravasation refers to the potential leakage of Evans blue dye from blood vessels into the surrounding tissues, which potentially indicates increased vascular permeability, possibly associated with inflammation. The histological analysis appeared to provide visual evidence of inflammation. The results indicated that the induction of periodontitis potentially induced an increase in Evans blue extravasation, histological signs of inflammation, and alveolar bone destruction. However, the exposure to BPC-157 appeared to significantly reduce plasma extravasation, histological alterations potentially associated with inflammation, and alveolar bone resorption.\u003csup\u003e[9]\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eBPC-157 and and the Central Nervous System\u003c\/strong\u003e\u003cbr\u003eThe potential of BPC-157 has been investigated in a murine model of traumatic brain injury (TBI), suggesting positive outcomes. The peptide appeared to lead to a significant attenuation of TBI-induced damage and improved early outcomes based on the observed experiments. During the 24-hour post-injury period, there seemed to be minimal mortality. The severity of traumatic lesions, such as subarachnoid and intraventricular hemorrhage, brain laceration, and hemorrhagic laceration, appeared to be less pronounced in the BPC-157 group. Furthermore, there seemed to be a considerable improvement in brain edema. Hypothetically, if introduced prior to TBI, BPC-157 may have exhibited an improved conscious\/unconscious\/death ratio. Moreover, the immediate presentation of BPC-157 before injury may have also reduced the damage in murine models subjected to a force impulse.\u003csup\u003e[10]\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp class=\"white-back-d\" style=\"margin-bottom: 30px !important;\"\u003e\u003cstrong\u003eBPC-157 and Bees\u003c\/strong\u003e\u003cbr\u003eColony collapse disorder (CCD) is a syndrome that causes entire colonies of bees to decline rapidly and die entirely, possibly due to \u003cem\u003eNosema ceranae\u003c\/em\u003e fungal infection in the GI tract of bees. The addition of BPC-157 in bee food noted significant improvement of the bee GI tract and hive survival. In this experimental research, the peptide appeared successful in natural field settings to reduce the impact of CCD on bees, important natural pollinators of many crop plants.\u003cb\u003e\u003cem\u003e\u003c\/em\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003ch3 style=\"color: #555;\"\u003eReferences\u003c\/h3\u003e\n\u003cdiv class=\"white-back-d\" style=\"padding-bottom: 5px !important; margin-bottom: 25px !important;\"\u003e\n\u003col style=\"color: #555;\"\u003e\n\u003cli\u003eJelovac, N., Sikirić, P., Rucman, R., Petek, M., Perović, D., Konjevoda, P., Marović, A., Seiwerth, S., Grabarević, Z., Sumajstorcić, J., Dodig, G., \u0026amp; Perić, J. (1998). A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine. Biological psychiatry, 43(7), 511–519.\u003c\/li\u003e\n\u003cli\u003eSikirić, P., Mazul, B., Seiwerth, S., Grabarević, Z., Rucman, R., Petek, M., Jagić, V., Turković, B., Rotkvić, I., Mise, S., Zoricić, I., Jurina, L., Konjevoda, P., Hanzevacki, M., Gjurasin, M., Separović, J., Ljubanović, D., Artuković, B., Bratulić, M., Tisljar, M., … Sumajstorcić, J. (1997). Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress. Digestive diseases and sciences, 42(3), 661–671.\u003c\/li\u003e\n\u003cli\u003eTkalcević, V. I., Cuzić, S., Brajsa, K., Mildner, B., Bokulić, A., Situm, K., Perović, D., Glojnarić, I., \u0026amp; Parnham, M. J. (2007). Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression. European journal of pharmacology, 570(1-3), 212–221.\u003c\/li\u003e\n\u003cli\u003eHuang, T., Zhang, K., Sun, L., Xue, X., Zhang, C., Shu, Z., Mu, N., Gu, J., Zhang, W., Wang, Y., Zhang, Y., \u0026amp; Zhang, W. (2015). Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. \u003ci\u003eDrug design, development and therapy\u003c\/i\u003e, \u003ci\u003e9\u003c\/i\u003e, 2485–2499.\u003c\/li\u003e\n\u003cli\u003eHsieh, M. J., Liu, H. T., Wang, C. N., Huang, H. Y., Lin, Y., Ko, Y. S., Wang, J. S., Chang, V. H., \u0026amp; Pang, J. S. (2017). Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of molecular medicine (Berlin, Germany), 95(3), 323–333.\u003c\/li\u003e\n\u003cli\u003eChang, C. H., Tsai, W. C., Lin, M. S., Hsu, Y. H., \u0026amp; Pang, J. H. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of applied physiology (Bethesda, Md. : 1985), 110(3), 774–780.\u003c\/li\u003e\n\u003cli\u003eŠkrlec, K., Ručman, R., Jarc, E., Sikirić, P., Švajger, U., Petan, T., Perišić Nanut, M., Štrukelj, B., \u0026amp; Berlec, A. (2018). Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities. Applied microbiology and biotechnology, 102(23), 10103–10117.\u003c\/li\u003e\n\u003cli\u003eKrivic, A., Majerovic, M., Jelic, I., Seiwerth, S., \u0026amp; Sikiric, P. (2008). Modulation of early functional recovery of Achilles tendon to bone unit after transection by BPC 157 and methylprednisolone. \u003ci\u003eInflammation research : official journal of the European Histamine Research Society ... [et al.]\u003c\/i\u003e, \u003ci\u003e57\u003c\/i\u003e(5), 205–210.\u003c\/li\u003e\n\u003cli\u003eKeremi, B., Lohinai, Z., Komora, P., Duhaj, S., Borsi, K., Jobbagy-Ovari, G., Kallo, K., Szekely, A. D., Fazekas, A., Dobo-Nagy, C., Sikiric, P., \u0026amp; Varga, G. (2009). Antiinflammatory effect of BPC 157 on experimental periodontitis in rats. \u003ci\u003eJournal of physiology and pharmacology : an official journal of the Polish Physiological Society\u003c\/i\u003e, \u003ci\u003e60 Suppl 7\u003c\/i\u003e, 115–122.\u003c\/li\u003e\n\u003cli\u003eTudor, M., Jandric, I., Marovic, A., Gjurasin, M., Perovic, D., Radic, B., Blagaic, A. B., Kolenc, D., Brcic, L., Zarkovic, K., Seiwerth, S., \u0026amp; Sikiric, P. (2010). Traumatic brain injury in mice and pentadecapeptide BPC 157 effect. \u003ci\u003eRegulatory peptides\u003c\/i\u003e, \u003ci\u003e160\u003c\/i\u003e(1-3), 26–32.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"author-details\"\u003e\n\u003ch2\u003e\u003ca href=\"https:\/\/biotechpeptides.com\/dr-marinov\/\"\u003eDr. Usman\u003c\/a\u003e\u003c\/h2\u003e\n\u003cp\u003eDr. Usman (BSc, MBBS, MaRCP) completed his studies in medicine at the Royal College of Physicians, London. He is an avid researcher with more than 30 publications in internationally recognized peer-reviewed journals. Dr. Usman has worked as a researcher and a medical consultant for reputable pharmaceutical companies such as Johnson \u0026amp; Johnson and Sanofi.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"mysite","offers":[{"title":"5mg \/ 10 Vials","offer_id":51786430218557,"sku":"sku2194756131508","price":180.0,"currency_code":"USD","in_stock":true},{"title":"10mg \/ 10 Vials","offer_id":51786430251325,"sku":"sku2194756131507","price":250.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0997\/4474\/3741\/files\/BPC-157-1-1.webp?v=1780466175"},{"product_id":"semax-25mg","title":"（🧠Stress relief） Semax Peptide (25mg) -10 Vials","description":"\u003cdiv class=\"et_pb_tab_content\"\u003e\n\u003cdiv class=\"pro-description-con\"\u003e\n\u003ch2\u003e🧠 Cognitive enhancement\u003cbr\u003e🎯 Focus\u003cbr\u003e📚 Learning and memory\u003cbr\u003e🛡️ Neuroprotection\u003cbr\u003e😌 Stress relief\u003c\/h2\u003e\n\u003ch2\u003eSemax Peptide\u003c\/h2\u003e\n\u003cp class=\"white-back-d\" style=\"margin-bottom: 30px;\"\u003eSemax is a synthetic analog of adrenocorticotropic hormone (ACTH) comprising the amino acids 4 through 10 of ACTH. Semax has primarily been implicated in research on cognitive impairment and stroke. The peptide has also been studied closely within the context of dementia and certain inflammations of the optic nerve. Researchers posit that the peptide may exert neurotrophic action, suggesting that the peptide may act to increase the production of brain-derived neurotrophic factor (BDNF) in the central nervous system, with potential consequences in serotonin and dopamine release. Some researchers also suggest that Semax may interact with serotonin and enkephalin levels in the central nervous system.\u003c\/p\u003e\n\u003ch3\u003eSpecifications\u003c\/h3\u003e\n\u003cp class=\"grey-back\"\u003e\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e C\u003csub\u003e39\u003c\/sub\u003eH\u003csub\u003e54\u003c\/sub\u003eN\u003csub\u003e10\u003c\/sub\u003eO\u003csub\u003e10\u003c\/sub\u003eS\u003c\/p\u003e\n\u003cp class=\"white-back\"\u003e\u003cstrong\u003eMolecular Weight:\u003c\/strong\u003e 854.99 g\/mol\u003c\/p\u003e\n\u003cp class=\"grey-back\" style=\"margin-bottom: 30px;\"\u003e\u003cstrong\u003eSequence:\u003c\/strong\u003e Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-lle-GluLys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-LysThr-Glu-Thr-Gin-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-GluThy-lleGlu-Gin-Glu-Lys-Gin-Ala-Gly-Glu-Ser\u003c\/p\u003e\n\u003ch3\u003eSemax Research\u003c\/h3\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eSemax and the Blood-Brain Barrier\u003c\/strong\u003e\u003cbr\u003eSemax is a synthetic heptapeptide consisting of the amino acid sequence Met-Glu-His-Phe, a partial sequence derived from the naturally occurring adrenocorticotropic hormone (ACTH). This primary sequence is further augmented by appending a Pro-Gly-Pro (PGP) tripeptide at the C-terminal end, a modification hypothesized to potentially increase the molecule's lipophilicity. Enhanced lipophilicity might, in turn, improve the peptide’s capacity for passive diffusion or uptake through the brain's protective blood-brain barrier (BBB). Such facilitation might occur via lipid raft-mediated endocytosis mechanisms, potentially allowing the peptide to bypass the tight junctions that normally impede substances from entering the brain. Additionally, incorporating the PGP sequence at the C-terminus of the peptide is posited to influence its interaction with specific transporters or receptors located on the BBB, which might promote its entry into the brain through receptor-mediated transcytosis. Furthermore, acetylating Semax may confer increased molecular stability, potentially rendering the peptide more resistant to enzymatic degradation. This alteration might result in an extended half-life of Semax within biological systems, allowing for a prolonged period of activity before breakdown occurs.\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eSemax and Stroke\u003c\/strong\u003e\u003cbr\u003eIn Russia, Semax has been researched in the context of acute cerebral hypoxia resulting from stroke or traumatic brain injury. As per studies in murine models, Semax appears to promote the expression of 24 genes in the brain and spinal cord through various molecular mechanisms. These genes are believed to modulate various functions, from smooth muscle cell migration to red blood cell formation and angiogenesis. The peptide has been suggested to promote the survival of neurons and potentially stabilize mitochondria.\u003csup\u003e[1]\u003c\/sup\u003e Scientists report that \u003cem\u003e“The immunomodulating effect of the peptide discovered in our research and its impact on the vascular system during ischemia is likely to be the key mechanisms underlying the neuroprotective effects of the peptide.”\u003c\/em\u003e \u003csup\u003e[2]\u003c\/sup\u003e Gusev et al. observed, \u003cem\u003e“early rehabilitation and [introduction] of Semax increased BDNF plasma levels, speed functional recovery, and improve motor performance.”\u003c\/em\u003e BDNF is a natural that some researchers believe may aid in cognitive development. There is data to suppose that BDNF stimulation may support neuroplasticity as well.\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eSemax and Brain Structure\u003c\/strong\u003e\u003cbr\u003eSemax has been suggested by researchers via functional magnetic resonance imaging to trigger the function of what is known as \u003cem\u003ethe default mode network\u003c\/em\u003e.\u003csup\u003e[3]\u003c\/sup\u003e The default mode network includes areas of the brain that remain more active during rest than during conscious activity. It is considered a general-purpose system for monitoring the organism’s environment without focusing on specific elements. The network is an important aspect of an organism’s attention capacity as it is believed to support the change from a “resting” state to alertness.\u003csup\u003e[4]\u003c\/sup\u003e Researchers suggest that increased activity in the default mode network may correspond to improved neural connections within the brain. These connections may support cognitive processes. Through closer research into Semax, researchers speculate that the peptide may support global brain function through a domino chain of cognitive functioning.\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eSemax and Gene Expression\u003c\/strong\u003e\u003cbr\u003eSemax appears to mediate changes in gene expression in the brain. Study findings indicate that introducing the peptide may trigger differential gene regulation in rats’ frontal cortex and hippocampus. This is relevant as the hippocampus regulates memory and learning, whereas the frontal cortex helps process and organize information. In both brain regions, scientists observed that gene expression spiked within 20 minutes of Semax exposure and specifically appeared to influence nerve growth factor (NGF) and BDNF.\u003csup\u003e[5]\u003c\/sup\u003e The researchers concluded that \u003cem\u003e“Semax … results in rapid, long-term, and specific activation of Bdnf and Ngf expression changes in different rat brain departments.”\u003c\/em\u003e\u003c\/p\u003e\n\u003cp class=\"white-back-d\"\u003e\u003cstrong\u003eSemax and Cognitive Function\u003c\/strong\u003e\u003cbr\u003eACTH, the natural protein source of Semax, appears to preserve memory function and learning in murine models of epilepsy, as suggested in studies published in Canada, China, and the United States. It has also been an object of speculation for its potential in epileptic disorder research. According to Dr. Scantlebury, Semax is a potentially potent derivative of ACTH and may provide ancillary action that is absent in the natural peptide.\u003csup\u003e[6]\u003c\/sup\u003e Preliminary reports suggest that even low concentrations of ACTH may mitigate the risk of dysfunction following a seizure. This research indicates ACTH and Semax may possess nootropic characteristics. Research is ongoing.\u003c\/p\u003e\n\u003cp class=\"grey-back-d\"\u003e\u003cstrong\u003eSemax and Serotonin Signaling\u003c\/strong\u003e\u003cbr\u003eSemax might potentially interact with and elevate serotonin levels, which may contribute to improved mood and reduced anxiety. The potential for Semax to affect neurotransmitter systems includes the possibility of restoring or stabilizing neural pathways. This action has the potential to balance the excitatory and inhibitory signals within the brain, fostering an environment more favorable to alleviating anxiety. This implies that the peptide's influence on neural circuits related to anxiety might be prolonged, thereby suggesting a lasting impact on these pathways.\u003csup\u003e[7]\u003c\/sup\u003e\u003cbr\u003e\u003cbr\u003eFurthermore, the sustained actions of Semax suggest it may play a role in either protecting or correcting neural circuits over an extended period beyond the initial exposure to the peptide. For example, in a series of murine model experiments, exposure to Semax was linked to altered levels of 5-hydroxyindoleacetic acid (5-HIAA), a major serotonin metabolite. This change suggests an enhancement of serotonergic activity, which is believed to be crucial for the neurotransmitter serotonin, which influences mood and cognitive functions. After exposure to Semax, a gradual increase in 5-HIAA levels was observed, rising to 180% over four hours.\u003csup\u003e[8]\u003c\/sup\u003e Additionally, it was observed that exposure to Semax 20 minutes prior to experimenting with D-amphetamine led to higher levels of 5-HIAA compared to when Semax was tested alone. Such findings indicate that Semax might play a role in modulating serotonin metabolism, potentially impacting serotonin-dependent pathways essential for regulating mood, cognitive processes, and overall brain function in test models.\u003c\/p\u003e\n\u003cp class=\"white-back-d\" style=\"margin-bottom: 30px;\"\u003e\u003cstrong\u003eSemax and Enkephalin Signaling\u003c\/strong\u003e\u003cbr\u003eRecent studies propose that specific enzymes, which may play a role in the breakdown of enkephalins, might be impeded by Semax, potentially leading to unique outcomes under laboratory conditions.\u003csup\u003e[9]\u003c\/sup\u003e Enkephalins are neurotransmitter substances produced in the brain that might play key roles in managing various biological processes. These neurotransmitters are thought to significantly impact nociception, which is the process by which pain is sensed by neurons and in stress response. Further, an increase in the levels of enkephalins may possibly influence the functioning of other neurotransmitter systems. This is due to the complex relationships between the opioid system, which includes enkephalins, and other neurotransmitter systems, such as those involving dopamine and serotonin. These relationships might manifest as changes in the release of neurotransmitters, variations in receptor activities, or alterations in signal transduction pathways.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e\u003cem\u003e Research chemicals are intended solely for laboratory experimentation and\/or in-vitro testing. Bodily introduction of any sort is strictly prohibited by law. All purchases are limited to licensed researchers and\/or qualified professionals. All information shared in this article is for educational purposes only.\u003c\/em\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3 style=\"color: #555;\"\u003eReferences\u003c\/h3\u003e\n\u003cdiv class=\"white-back-d\" style=\"padding-bottom: 5px !important; margin-bottom: 25px !important;\"\u003e\n\u003col style=\"color: #555;\"\u003e\n\u003cli\u003eMedvedeva EV, Dmitrieva VG, Povarova OV, et al. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics. 2014;15:228. Published 2014 Mar 24. .\u003c\/li\u003e\n\u003cli\u003eGusev EI, Martynov MY, Kostenko EV, Petrova LV, Bobyreva SN. Éffektivnost’ semaksa pri lechenii bol’nykh na raznykh stadiiakh ishemicheskogo insul’ta [The efficacy of semax in the treatment of patients at different stages of ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(3. Vyp. 2):61-68. .\u003c\/li\u003e\n\u003cli\u003eLebedeva IS, Panikratova YR, Sokolov OY, et al. Effects of Semax on the Default Mode Network of the Brain. Bull Exp Biol Med. 2018;165(5):653-656. .\u003c\/li\u003e\n\u003cli\u003eMars RB, Neubert FX, Noonan MP, Sallet J, Toni I, Rushworth MF. On the relationship between the “default mode network” and the “social brain”. Front Hum Neurosci. 2012;6:189. Published 2012 Jun 21. .\u003c\/li\u003e\n\u003cli\u003eAgapova TIu, Agniullin IaV, Silachev DN, et al. Mol Gen Mikrobiol Virusol. 2008;(3):28-32.\u003c\/li\u003e\n\u003cli\u003eScantlebury MH, Chun KC, Ma SC, Rho JM, Kim DY. Adrenocorticotropic hormone protects learning and memory function in epileptic Kcna1-null mice. Neurosci Lett. 2017;645:14-18.\u003c\/li\u003e\n\u003cli\u003eNataliya Yu. Glazova, Daria M. Manchenko, Maria A. Volodina, Svetlana A. Merchieva, Ludmila A. Andreeva, Vladimir S. Kudrin, Nikolai F. Myasoedov, Natalia G. Levitskaya, Semax, synthetic ACTH(4–10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats, Neuropeptides, Volume 86, 2021, 102114, ISSN 0143-4179.\u003c\/li\u003e\n\u003cli\u003eEremin KO, Kudrin VS, Saransaari P, Oja SS, Grivennikov IA, Myasoedov NF, Rayevsky KS. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochem Res. 2005 Dec;30(12):1493-500. . PMID: 16362768.\u003c\/li\u003e\n\u003cli\u003eKost NV, Sokolov OIu, Gabaeva MV, Grivennikov IA, Andreeva LA, Miasoedov NF, Zozulia AA. Ingibiruiushchee deĭstvie semaksa i selanka na énkefalindegradiruiushchie fermenty syvorotki krovi cheloveka [Semax and selank inhibit the enkephalin-degrading enzymes from human serum]]. Bioorg Khim. 2001 May-Jun;27(3):180-3. Russian. doi: 10.1023\/a:1011373002885. PMID: 11443939.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"author-details\"\u003e\n\u003ch2\u003e\u003ca href=\"https:\/\/biotechpeptides.com\/dr-marinov\/\"\u003eDr. Usman\u003c\/a\u003e\u003c\/h2\u003e\n\u003cp\u003eDr. Usman (BSc, MBBS, MaRCP) completed his studies in medicine at the Royal College of Physicians, London. He is an avid researcher with more than 30 publications in internationally recognized peer-reviewed journals. Dr. Usman has worked as a researcher and a medical consultant for reputable pharmaceutical companies such as Johnson \u0026amp; Johnson and Sanofi.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"mysite","offers":[{"title":"Default Title","offer_id":51786430316861,"sku":"sku2194756142613","price":150.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0997\/4474\/3741\/files\/SEMAX-25MG-2-1.webp?v=1780466177"},{"product_id":"reconstitution-solution","title":"💧（ Dissolving Peptide Powders）Reconstitution Solution","description":"\u003cp\u003eProduct Features 🌟\u003cbr\u003e🔬 Preserves Bioactivity – Protects the integrity and activity of sensitive peptides such as semaglutide, BPC-157, CJC-1295, and others\u003cbr\u003e🔄 Versatile Compatibility – Suitable for water-soluble peptide powders and most proteins, supporting a wide range of experimental applications\u003cbr\u003e🧴 Sterile and Ready-to-Use – Prepared under sterile conditions to ensure clean, contamination-free reconstitution\u003cbr\u003e✨ Easy to Use – Designed for laboratories requiring precise dissolution and minimal handling effort\u003c\/p\u003e\n\u003cp\u003eInstructions for Use 📝\u003cbr\u003e✅ Identify the peptide type and refer to the specific reconstitution guidelines\u003cbr\u003e💧 Add the recommended volume of reconstitution solution to the lyophilized vial\u003cbr\u003e🔄 Gently swirl or shake slowly until completely dissolved; avoid vigorous shaking to prevent degradation\u003cbr\u003e⏱️ Use immediately after dissolution, or store according to the peptide’s stability conditions\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003ePeptide\u003c\/th\u003e\n\u003cth\u003eCommon Vial Size\u003c\/th\u003e\n\u003cth\u003eCommon BAC Water Added\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTirzepatide\u003c\/td\u003e\n\u003ctd\u003e5mg \/ 10mg \/ 30mg\u003c\/td\u003e\n\u003ctd\u003e1–3mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCJC-1295 No DAC\u003c\/td\u003e\n\u003ctd\u003e2mg \/ 5mg\u003c\/td\u003e\n\u003ctd\u003e1–2mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIpamorelin\u003c\/td\u003e\n\u003ctd\u003e2mg \/ 5mg\u003c\/td\u003e\n\u003ctd\u003e1–2mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTesamorelin\u003c\/td\u003e\n\u003ctd\u003e2mg \/ 10mg\u003c\/td\u003e\n\u003ctd\u003evaries\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTB-500\u003c\/td\u003e\n\u003ctd\u003e2mg \/ 5mg \/ 10mg\u003c\/td\u003e\n\u003ctd\u003e1–3mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp data-start=\"404\" data-end=\"420\"\u003eMost people use:\u003c\/p\u003e\n\u003cul data-start=\"421\" data-end=\"502\"\u003e\n\u003cli data-section-id=\"1ofjm6s\" data-start=\"421\" data-end=\"461\"\u003e\u003cstrong data-start=\"423\" data-end=\"459\"\u003eBacteriostatic Water (BAC water)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli data-section-id=\"1v3helu\" data-start=\"462\" data-end=\"502\"\u003eInsulin syringes for dosing accuracy\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"504\" data-end=\"531\"\u003eA common beginner setup is:\u003c\/p\u003e\n\u003cul data-start=\"532\" data-end=\"612\"\u003e\n\u003cli data-section-id=\"kywz2b\" data-start=\"532\" data-end=\"612\"\u003e\n\u003cstrong data-start=\"534\" data-end=\"565\"\u003e5mg peptide + 2mL BAC water\u003c\/strong\u003e\u003cbr data-start=\"565\" data-end=\"568\"\u003ebecause it makes dosing easier to calculate.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"614\" data-end=\"622\"\u003eExample:\u003c\/p\u003e\n\u003cul data-start=\"623\" data-end=\"681\"\u003e\n\u003cli data-section-id=\"1x9oiku\" data-start=\"623\" data-end=\"636\"\u003e5mg peptide\u003c\/li\u003e\n\u003cli data-section-id=\"107abqn\" data-start=\"637\" data-end=\"652\"\u003eAdd 2mL water\u003c\/li\u003e\n\u003cli data-section-id=\"16l0lo1\" data-start=\"653\" data-end=\"681\"\u003eResult:\n\u003cul data-start=\"665\" data-end=\"681\"\u003e\n\u003cli data-section-id=\"1r1mx5x\" data-start=\"665\" data-end=\"681\"\u003e0.1mL = 250mcg\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cimg alt=\"\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0996\/9745\/9490\/files\/27d408ec-2f04-47b7-adde-7a3290356cee.png?v=1779421016\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBacteriostatic Water\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a sterile aqueous solution containing\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e0.9% benzyl alcohol\u003c\/strong\u003e, formulated to inhibit the growth and proliferation of microorganisms without directly destroying them. This bacteriostatic property makes it a critical resource in\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003elaboratory, experimental, and research environments\u003c\/strong\u003e, where sterility, chemical stability, and repeated vial access are essential.\u003c\/p\u003e\n\u003cp\u003eWithin controlled research workflows, bacteriostatic water is most commonly utilized as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003ediluent for the reconstitution of lyophilized (freeze-dried) research compounds\u003c\/strong\u003e, including peptides, proteins, and other sensitive materials that require precise hydration prior to experimental application. The presence of benzyl alcohol allows the solution to remain bacteriostatic after initial vial access, provided that\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003estrict aseptic techniques\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eare maintained throughout handling.\u003c\/p\u003e\n\u003cp\u003eUnlike preservative-free sterile water, which is intended for\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003esingle-use laboratory applications\u003c\/strong\u003e, bacteriostatic water is designed to support\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003emulti-dose access in controlled research settings\u003c\/strong\u003e. This reduces material waste, supports procedural efficiency, and lowers the risk of accidental microbial introduction during repeated laboratory manipulation.\u003c\/p\u003e\n\u003cp\u003eWhen used in conjunction with\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003ehigh-purity research materials\u003c\/strong\u003e, including\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eLPS-free peptides\u003c\/strong\u003e,\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eendotoxin-free peptides\u003c\/strong\u003e, and\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eresearch peptides that are endotoxin tested\u003c\/strong\u003e, bacteriostatic water contributes to maintaining experimental consistency and reproducibility. Its formulation supports predictable dilution behavior and helps preserve the\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003echemical stability and structural integrity\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eof sensitive research compounds over extended study timelines.\u003c\/p\u003e\n\u003cp\u003eIt is important to note that while benzyl alcohol suppresses microbial growth, it does\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003enot sterilize contaminated solutions\u003c\/strong\u003e. Therefore, comprehensive laboratory sanitation protocols, validated storage conditions, and disciplined handling practices remain mandatory.\u003c\/p\u003e\n\u003cp\u003eDue to these properties, bacteriostatic water has become a foundational component in modern research laboratories where\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eprecision, sterility, and compound integrity\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eare required across long-term experimental programs.\u003c\/p\u003e\n\u003cp\u003e“\u003cstrong\u003eNote\u003c\/strong\u003e:\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eBacteriostatic Water\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis sold as a research reagent for peptide reconstitution. It is not a medical product and must not be used for any human or veterinary injection.”\u003c\/p\u003e\n\u003cdiv class=\"text-lg-center mb-4\"\u003e\n\u003ch2 class=\"recon-title\"\u003eReconstitution Guide\u003c\/h2\u003e\n\u003cp class=\"recon-subtitle\"\u003eStandard reconstitution protocol for lyophilized Reconstitution Solution using bacteriostatic water.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row g-5\"\u003e\n\u003cdiv class=\"col-lg-4\"\u003e\n\u003cdiv class=\"recon-card\"\u003e\n\u003cdiv class=\"recon-step\"\u003e[1]\u003c\/div\u003e\n\u003ch4\u003ePrepare Aseptic Environment\u003c\/h4\u003e\n\u003cp\u003eEnsure all equipment is sterile. Work under aseptic conditions — laminar flow hood preferred. Swab both vial stoppers with 70% isopropyl alcohol and allow to fully air-dry before puncturing.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-lg-4\"\u003e\n\u003cdiv class=\"recon-card\"\u003e\n\u003cdiv class=\"recon-step\"\u003e[2]\u003c\/div\u003e\n\u003ch4\u003eReconstitute with BAC Water\u003c\/h4\u003e\n\u003cp\u003eUsing a sterile syringe, draw the calculated volume of bacteriostatic water. Inject slowly into the Reconstitution Solution vial along the glass wall. Do not shake. Gently swirl until fully dissolved.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-lg-4\"\u003e\n\u003cdiv class=\"recon-card\"\u003e\n\u003cdiv class=\"recon-step\"\u003e[3]\u003c\/div\u003e\n\u003ch4\u003eStore and Document\u003c\/h4\u003e\n\u003cp\u003eReconstituted Reconstitution Solution should be stored at 2–8°C and used within 28 days. Discard immediately if cloudiness or particulates appear. Unopened lyophilized vials remain stable at -20°C for up to 24 months.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"recon-note\"\u003e\n\u003cbr\u003e\n\u003cdiv\u003e\n\u003cstrong\u003eEndotoxin Note:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eReconstitution Solution is endotoxin-screened at the compound level. Full LAL test results available in the product COA.\n\u003ch2 class=\"vendor-title\"\u003eWhy Researchers Choose Licensed Peptides\u003c\/h2\u003e\n\u003cp class=\"vendor-subtitle\"\u003eNot all peptide vendors hold themselves to the same verification standards.\u003c\/p\u003e\n\u003cdiv class=\"table-responsive vendor-table-wrap\"\u003e\n\u003ctable class=\"table vendor-table align-middle\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth scope=\"col\"\u003eVerification Standard\u003c\/th\u003e\n\u003cth class=\"lp-col\" scope=\"col\"\u003eLicensed Peptides\u003c\/th\u003e\n\u003cth class=\"gv-col\" scope=\"col\"\u003eGeneric Vendors\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHPLC Purity Analysis\u003c\/td\u003e\n\u003ctd class=\"lp-col\"\u003e\n\u003cimg alt=\"✓\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table_tick.svg\" loading=\"lazy\"\u003e\u003cspan\u003e \u003c\/span\u003e99%+ Every Batch\u003c\/td\u003e\n\u003ctd class=\"gv-col\"\u003e\n\u003cimg alt=\"✗\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table-cross.svg\" loading=\"lazy\"\u003e\u003cspan\u003e \u003c\/span\u003eOften Not Disclosed\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMass Spectrometry Identity\u003c\/td\u003e\n\u003ctd class=\"lp-col\"\u003e\n\u003cimg alt=\"✓\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table_tick.svg\" loading=\"lazy\"\u003e\u003cspan\u003e \u003c\/span\u003eSequence Confirmed\u003c\/td\u003e\n\u003ctd class=\"gv-col\"\u003e\n\u003cimg alt=\"✗\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table-cross.svg\" loading=\"lazy\"\u003e\u003cspan\u003e \u003c\/span\u003eRarely Available\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEndotoxin Screening (LAL)\u003c\/td\u003e\n\u003ctd class=\"lp-col\"\u003e\n\u003cimg alt=\"✓\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table_tick.svg\" loading=\"lazy\"\u003e\u003cspan\u003e \u003c\/span\u003eEvery Product\u003c\/td\u003e\n\u003ctd class=\"gv-col\"\u003e\n\u003cimg alt=\"✗\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table-cross.svg\" loading=\"lazy\"\u003e\u003cspan\u003e \u003c\/span\u003eIndustry Exception\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGMP-Certified USA Manufacture\u003c\/td\u003e\n\u003ctd class=\"lp-col\"\u003e\n\u003cimg alt=\"✓\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table_tick.svg\" loading=\"lazy\"\u003e\u003cspan\u003e \u003c\/span\u003eISO 9001:2015\u003c\/td\u003e\n\u003ctd class=\"gv-col\"\u003e\n\u003cimg alt=\"✗\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table-cross.svg\" loading=\"lazy\"\u003e\u003cspan\u003e \u003c\/span\u003eOften Overseas\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCOA Published \u0026amp; Downloadable\u003c\/td\u003e\n\u003ctd class=\"lp-col\"\u003e\n\u003cimg alt=\"✓\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table_tick.svg\" loading=\"lazy\"\u003e\u003cspan\u003e \u003c\/span\u003eEvery Lot\u003c\/td\u003e\n\u003ctd class=\"gv-col\"\u003e\n\u003cimg alt=\"✗\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table-cross.svg\" loading=\"lazy\"\u003e\u003cspan\u003e \u003c\/span\u003eInconsistent\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSame-Day USA Fulfillment\u003c\/td\u003e\n\u003ctd class=\"lp-col\"\u003e\n\u003cimg alt=\"✓\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table_tick.svg\" loading=\"lazy\"\u003e\u003cspan\u003e \u003c\/span\u003eBefore 4PM PST\u003c\/td\u003e\n\u003ctd class=\"gv-col\"\u003e\n\u003cimg alt=\"✗\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table-cross.svg\" loading=\"lazy\"\u003e\u003cspan\u003e \u003c\/span\u003e3-10 Day Lead Time\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cdiv class=\"text-lg-center\"\u003e\n\u003ch2 class=\"faq-title\"\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row justify-content-center\"\u003e\n\u003cdiv class=\"col-md-8\"\u003e\n\u003cdiv class=\"faq-wrap\"\u003e\n\u003cdiv class=\"accordion faq-accordion\" id=\"faqAccordion\"\u003e\n\u003cdiv class=\"accordion-item\"\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_0\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_0\" aria-expanded=\"true\" aria-controls=\"faqCollapse_0\"\u003e\u003cspan class=\"faq-q\"\u003e1. What is Bacteriostatic Water?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_0\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_0\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eBacteriostatic Water is a sterile water solution containing\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e0.9% benzyl alcohol\u003c\/strong\u003e, which functions as a preservative to inhibit bacterial growth. This formulation allows the solution to remain usable for multiple withdrawals over a defined period when handled properly under aseptic laboratory conditions.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_1\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_1\" aria-expanded=\"true\" aria-controls=\"faqCollapse_1\"\u003e\u003cspan class=\"faq-q\"\u003e2. What is the purpose of Bacteriostatic Water in research?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_1\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_1\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eThis bacteriostatic water is sold as a research reagent for peptide reconstitution. It is not a medical product and must not be used for any human or veterinary injection.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_2\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_2\" aria-expanded=\"true\" aria-controls=\"faqCollapse_2\"\u003e\u003cspan class=\"faq-q\"\u003e3. What is the difference between sterile water and bacteriostatic water?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_2\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_2\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eSterile water contains\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eno preservatives\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eand is intended for single-use applications only. Bacteriostatic water includes benzyl alcohol, permitting multi-dose use within controlled laboratory settings.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_3\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_3\" aria-expanded=\"true\" aria-controls=\"faqCollapse_3\"\u003e\u003cspan class=\"faq-q\"\u003e4. Why is Bacteriostatic Water commonly used in peptide research?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_3\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_3\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003ePeptides and similar research compounds often require a stable, sterile diluent. Bacteriostatic water provides predictable reconstitution behavior and supports repeated access without immediate contamination risk.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_4\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_4\" aria-expanded=\"true\" aria-controls=\"faqCollapse_4\"\u003e\u003cspan class=\"faq-q\"\u003e5. What makes Bacteriostatic Water different from saline?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_4\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_4\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eSaline contains sodium chloride, whereas bacteriostatic water contains only sterile water and benzyl alcohol. They are not interchangeable unless specifically indicated by research protocols.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_5\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_5\" aria-expanded=\"true\" aria-controls=\"faqCollapse_5\"\u003e\u003cspan class=\"faq-q\"\u003e6. Is Bacteriostatic Water designed for multiple withdrawals?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_5\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_5\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eYes. The presence of benzyl alcohol allows the solution to remain bacteriostatic, supporting repeated vial access when proper aseptic techniques are consistently followed.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_6\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_6\" aria-expanded=\"true\" aria-controls=\"faqCollapse_6\"\u003e\u003cspan class=\"faq-q\"\u003e7. How long does Bacteriostatic Water remain usable after opening?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_6\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_6\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eWhen stored correctly and handled aseptically, bacteriostatic water is generally viable for\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eup to 28 days\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003efollowing the first vial puncture. \u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_7\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_7\" aria-expanded=\"true\" aria-controls=\"faqCollapse_7\"\u003e\u003cspan class=\"faq-q\"\u003e8. Does Bacteriostatic Water contain alcohol?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_7\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_7\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eYes. It contains\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e0.9% benzyl alcohol\u003c\/strong\u003e, which serves solely as a preservative to inhibit microbial growth.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_8\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_8\" aria-expanded=\"true\" aria-controls=\"faqCollapse_8\"\u003e\u003cspan class=\"faq-q\"\u003e9. Is refrigeration required after opening?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_8\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_8\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eRefrigeration is not strictly required but is often preferred in laboratory settings to help support prolonged stability after opening.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_9\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_9\" aria-expanded=\"true\" aria-controls=\"faqCollapse_9\"\u003e\u003cspan class=\"faq-q\"\u003e10. Can Bacteriostatic Water be used alone as a research substance?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_9\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_9\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eNo. It is intended exclusively as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003ediluent or reconstitution medium\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003efor other research compounds.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_10\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_10\" aria-expanded=\"true\" aria-controls=\"faqCollapse_10\"\u003e\u003cspan class=\"faq-q\"\u003e11. What should be done if particles or cloudiness appear?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_10\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_10\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eIf the solution shows any discoloration, cloudiness, or visible particles, it should be\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003ediscarded immediately\u003c\/strong\u003e, as this may indicate contamination.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_11\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_11\" aria-expanded=\"true\" aria-controls=\"faqCollapse_11\"\u003e\u003cspan class=\"faq-q\"\u003e12. Why does Bacteriostatic Water typically cost more than sterile water?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_11\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_11\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eThe inclusion of a preservative, multi-dose design and more stringent production standards contribute to its higher cost, along with its extended usability.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_12\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_12\" aria-expanded=\"true\" aria-controls=\"faqCollapse_12\"\u003e\u003cspan class=\"faq-q\"\u003e13. How can researchers verify if their Bacteriostatic Water is still viable?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_12\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_12\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eResearchers should confirm that:\u003c\/p\u003e\n\u003cp\u003eThe solution remains clear and particle-free\u003c\/p\u003e\n\u003cp\u003eThe expiration date has not passed\u003c\/p\u003e\n\u003cp\u003eFewer than 28 days have elapsed since initial use\u003c\/p\u003e\n\u003cdiv id=\"faqCollapse_13\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_13\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_14\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_14\" aria-expanded=\"true\" aria-controls=\"faqCollapse_14\"\u003e\u003cspan class=\"faq-q\"\u003e15. Why is bacteriostatic water preferred when working with LPS-free peptides?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_14\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_14\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eBacteriostatic water supports controlled reconstitution of\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eLPS-free peptides\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eby reducing the risk of microbial proliferation during repeated vial access, helping preserve low endotoxin conditions critical for sensitive research assays.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_15\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_15\" aria-expanded=\"true\" aria-controls=\"faqCollapse_15\"\u003e\u003cspan class=\"faq-q\"\u003e16. Is bacteriostatic water suitable for endotoxin-free peptide studies?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_15\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_15\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eYes. When paired with\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eendotoxin-free peptides\u003c\/strong\u003e, bacteriostatic water helps maintain solution integrity during multi-use laboratory workflows, provided endotoxin-controlled handling and storage protocols are followed.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_16\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_16\" aria-expanded=\"true\" aria-controls=\"faqCollapse_16\"\u003e\u003cspan class=\"faq-q\"\u003e17. How does bacteriostatic water support research peptides that are endotoxin tested?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_16\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_16\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eFor\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eresearch peptides endotoxin tested\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eprior to use, bacteriostatic water enables consistent dilution and repeat access without significantly increasing microbial risk, supporting reproducible experimental outcomes.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_17\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_17\" aria-expanded=\"true\" aria-controls=\"faqCollapse_17\"\u003e\u003cspan class=\"faq-q\"\u003e18. Does bacteriostatic water remove endotoxins from peptides?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_17\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_17\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eNo. Bacteriostatic water does not neutralize or remove endotoxins. It is used strictly as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003econtrolled diluent\u003c\/strong\u003e, and endotoxin control depends on peptide purity, validated testing, and proper laboratory handling\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"mysite","offers":[{"title":"3ml \/ 10 Vials","offer_id":51786430579005,"sku":null,"price":20.0,"currency_code":"USD","in_stock":true},{"title":"10ml \/ 10 Vials","offer_id":51786430611773,"sku":null,"price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0997\/4474\/3741\/files\/BAC-WATER-compressed.jpg?v=1780466183"},{"product_id":"kisspeptin-10","title":"💕（Enhance Sexual Function \u0026 Address Premature Ejaculation）Kisspeptin-10","description":"\u003cp\u003e🌟 Kisspeptin-10 – Lyophilized Peptide Powder 🌟\u003c\/p\u003e\n\u003cp\u003eSpecifications: 10 mg\u003cbr\u003eForm: Lyophilized powder (must be dissolved before injection)\u003cbr\u003eIntended Use: For use as a health supplement via injection\u003c\/p\u003e\n\u003cp\u003e🧬 Product Overview\u003cbr\u003eKisspeptin-10 is a high-purity freeze-dried peptide powder administered via subcutaneous injection. It supports the body’s natural hormonal regulation, boosts vitality, and helps maintain overall metabolic function and health. The freeze-dried powder form better preserves peptide activity, ensuring more stable and efficient absorption✨\u003c\/p\u003e\n\u003cp\u003e🌱 Key Ingredients\u003cbr\u003e🔹 Kisspeptin-10 Active Peptide (10mg)\u003cbr\u003eSupports endocrine balance and vitality regulation⚡\u003cbr\u003e🔹 Lyophilized Powder Form\u003cbr\u003eFor injection; the peptide is rapidly absorbed💧\u003cbr\u003e💖 Benefits for the Body\u003cbr\u003e⚡ Boosts Vitality and Energy\u003cbr\u003eSupports the body’s natural energy regulation, making daily life feel easier and reducing fatigue.\u003cbr\u003e🔄 Supports Metabolic Balance\u003cbr\u003eHelps the body maintain a normal metabolic rhythm and improves the efficiency of nutrient and energy utilization.\u003cbr\u003e💪 Promotes Physical Recovery\u003cbr\u003eSupports tissue and muscle health, aiding recovery after daily exercise.\u003cbr\u003e🧠 Supports endocrine balance\u003cbr\u003eHelps the body maintain a stable state, ensuring coordinated functioning of all systems.\u003cbr\u003e❤️ Enhances overall health\u003cbr\u003eSupports the coordinated functioning of bodily systems, helping the body maintain long-term stability and vitality.\u003c\/p\u003e\n\u003cp\u003e💉 Usage Recommendations (Injection)\u003cbr\u003eDissolve the lyophilized powder according to the instructions and administer via subcutaneous injection\u003cbr\u003eRecommended for use in conjunction with a regular sleep schedule, a healthy diet, and moderate exercise.\u003cbr\u003eRotate injection sites (abdomen, outer thigh, or outer upper arm).\u003cbr\u003eMaintain aseptic technique before and after use to ensure hygiene and safety.\u003c\/p\u003e\n\u003cp\u003e❄️ Storage Instructions\u003cbr\u003eStore unused lyophilized powder in the refrigerator (2–8°C).\u003cbr\u003eAvoid direct sunlight and high temperatures.\u003cbr\u003eOnce dissolved, use as soon as possible according to the instructions.\u003c\/p\u003e","brand":"mysite","offers":[{"title":"5mg \/ 10 Vials","offer_id":51786431267133,"sku":null,"price":200.0,"currency_code":"USD","in_stock":true},{"title":"10mg \/ 10 Vials","offer_id":51786431299901,"sku":null,"price":300.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0997\/4474\/3741\/files\/KISSPEPTIN-compressed.jpg?v=1780466194"},{"product_id":"semax-30mg","title":"🧠🌱（Boosts Mental Alertness and Focus ）Semax · 30mg","description":"\u003cp\u003e🌟 Semax – 30mg Lyophilized Peptide Powder 🌟\u003c\/p\u003e\n\u003cp\u003eSpecifications: 30mg\u003cbr\u003eForm: Lyophilized powder (must be dissolved or used as directed)\u003cbr\u003eUsage: For health support via injection or intranasal administration\u003c\/p\u003e\n\u003cp\u003e🧬 Product Overview\u003cbr\u003eSemax is a high-purity lyophilized peptide powder that can be administered via subcutaneous injection or intranasal inhalation. It helps boost neural vitality, improve blood circulation and overall physical condition, while enhancing energy and vitality to make daily life more efficient✨.\u003c\/p\u003e\n\u003cp\u003e🌱 Key Ingredients\u003cbr\u003eSemax Active Peptide (30mg)\u003cbr\u003eSupports nervous system health and systemic metabolic regulation⚡\u003cbr\u003eFreeze-Dried Powder Form\u003cbr\u003eFor injection or nasal use; the active peptides are rapidly absorbed💧\u003c\/p\u003e\n\u003cp\u003e💖 Benefits for the Body\u003cbr\u003eBoosts Mental Alertness and Focus 🧠\u003cbr\u003eSupports nervous system health, improving focus and mental clarity.\u003cbr\u003eImproves Blood Circulation 🔄\u003cbr\u003eSupports blood flow and microcirculation, enhancing the delivery of oxygen and nutrients.\u003cbr\u003eBoosts Energy and Vitality ⚡\u003cbr\u003eIncreases daily energy levels, reduces fatigue, and makes the body feel lighter.\u003cbr\u003ePromotes Tissue Repair and Health 🩹\u003cbr\u003eSupports the natural repair of soft tissues and cells, maintaining overall health.\u003cbr\u003eHolistic Health Support ❤️\u003cbr\u003eSupports the balanced functioning of bodily systems, maintaining long-term health.\u003c\/p\u003e\n\u003cp\u003e💉 \/ 👃 Usage Recommendations\u003cbr\u003eDissolve the freeze-dried powder according to instructions before injecting or using via nasal inhalation.\u003cbr\u003eUse daily at the recommended dosage; best results are achieved when combined with a healthy diet and moderate exercise.\u003cbr\u003eWhen injecting, it is recommended to rotate injection sites (abdomen, outer thigh, or outer upper arm).\u003cbr\u003eWhen using nasally, please follow safety guidelines and maintain good hygiene.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSemax 30mg\u003c\/strong\u003e\u003cspan\u003e is a laboratory research peptide used to study peptide behavior, receptor interactions, and cellular signaling pathways in controlled experimental systems. This product is supplied strictly for research use only.\u003c\/span\u003e\u003c\/p\u003e\n\u003csection class=\"reconstitution-section\"\u003e\n\u003cdiv class=\"container-new\"\u003e\n\u003cdiv class=\"text-lg-center mb-4\"\u003e\n\u003ch2 class=\"recon-title\"\u003eReconstitution Guide\u003c\/h2\u003e\n\u003cp class=\"recon-subtitle\"\u003eStandard reconstitution protocol for lyophilized Semax 30mg using bacteriostatic water.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row g-5\"\u003e\n\u003cdiv class=\"col-lg-4\"\u003e\n\u003cdiv class=\"recon-card\"\u003e\n\u003cdiv class=\"recon-step\"\u003e[1]\u003c\/div\u003e\n\u003ch4\u003ePrepare Aseptic Environment\u003c\/h4\u003e\n\u003cp\u003eEnsure all equipment is sterile. Work under aseptic conditions — laminar flow hood preferred. Swab both vial stoppers with 70% isopropyl alcohol and allow to fully air-dry before puncturing.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-lg-4\"\u003e\n\u003cdiv class=\"recon-card\"\u003e\n\u003cdiv class=\"recon-step\"\u003e[2]\u003c\/div\u003e\n\u003ch4\u003eReconstitute with BAC Water\u003c\/h4\u003e\n\u003cp\u003eUsing a sterile syringe, draw the calculated volume of bacteriostatic water. Inject slowly into the Semax 30mg vial along the glass wall. Do not shake. Gently swirl until fully dissolved.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-lg-4\"\u003e\n\u003cdiv class=\"recon-card\"\u003e\n\u003cdiv class=\"recon-step\"\u003e[3]\u003c\/div\u003e\n\u003ch4\u003eStore and Document\u003c\/h4\u003e\n\u003cp\u003eReconstituted Semax 30mg should be stored at 2–8°C and used within 28 days. Discard immediately if cloudiness or particulates appear. Unopened lyophilized vials remain stable at -20°C for up to 24 months.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"recon-note\"\u003e\n\u003cbr\u003e\n\u003cdiv\u003e\n\u003cstrong\u003eEndotoxin Note:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eSemax 30mg is endotoxin-screened at the compound level. Full LAL test results available in the product COA.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"vendor-section\"\u003e\n\u003cdiv class=\"container-new\"\u003e\n\u003cspan class=\"vendor-tag\"\u003eVendor Comparison\u003c\/span\u003e\n\u003ch2 class=\"vendor-title\"\u003eWhy Researchers Choose Licensed Peptides\u003c\/h2\u003e\n\u003cp class=\"vendor-subtitle\"\u003eNot all peptide vendors hold themselves to the same verification standards.\u003c\/p\u003e\n\u003cdiv class=\"table-responsive vendor-table-wrap\"\u003e\n\u003ctable class=\"table vendor-table align-middle\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth scope=\"col\"\u003eVerification Standard\u003c\/th\u003e\n\u003cth scope=\"col\" class=\"lp-col\"\u003eLicensed Peptides\u003c\/th\u003e\n\u003cth scope=\"col\" class=\"gv-col\"\u003eGeneric Vendors\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHPLC Purity Analysis\u003c\/td\u003e\n\u003ctd class=\"lp-col\"\u003e\n\u003cimg loading=\"lazy\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table_tick.svg\" alt=\"✓\"\u003e\u003cspan\u003e \u003c\/span\u003e99%+ Every Batch\u003c\/td\u003e\n\u003ctd class=\"gv-col\"\u003e\n\u003cimg loading=\"lazy\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table-cross.svg\" alt=\"✗\"\u003e\u003cspan\u003e \u003c\/span\u003eOften Not Disclosed\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMass Spectrometry Identity\u003c\/td\u003e\n\u003ctd class=\"lp-col\"\u003e\n\u003cimg loading=\"lazy\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table_tick.svg\" alt=\"✓\"\u003e\u003cspan\u003e \u003c\/span\u003eSequence Confirmed\u003c\/td\u003e\n\u003ctd class=\"gv-col\"\u003e\n\u003cimg loading=\"lazy\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table-cross.svg\" alt=\"✗\"\u003e\u003cspan\u003e \u003c\/span\u003eRarely Available\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEndotoxin Screening (LAL)\u003c\/td\u003e\n\u003ctd class=\"lp-col\"\u003e\n\u003cimg loading=\"lazy\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table_tick.svg\" alt=\"✓\"\u003e\u003cspan\u003e \u003c\/span\u003eEvery Product\u003c\/td\u003e\n\u003ctd class=\"gv-col\"\u003e\n\u003cimg loading=\"lazy\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table-cross.svg\" alt=\"✗\"\u003e\u003cspan\u003e \u003c\/span\u003eIndustry Exception\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGMP-Certified USA Manufacture\u003c\/td\u003e\n\u003ctd class=\"lp-col\"\u003e\n\u003cimg loading=\"lazy\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table_tick.svg\" alt=\"✓\"\u003e\u003cspan\u003e \u003c\/span\u003eISO 9001:2015\u003c\/td\u003e\n\u003ctd class=\"gv-col\"\u003e\n\u003cimg loading=\"lazy\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table-cross.svg\" alt=\"✗\"\u003e\u003cspan\u003e \u003c\/span\u003eOften Overseas\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCOA Published \u0026amp; Downloadable\u003c\/td\u003e\n\u003ctd class=\"lp-col\"\u003e\n\u003cimg loading=\"lazy\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table_tick.svg\" alt=\"✓\"\u003e\u003cspan\u003e \u003c\/span\u003eEvery Lot\u003c\/td\u003e\n\u003ctd class=\"gv-col\"\u003e\n\u003cimg loading=\"lazy\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table-cross.svg\" alt=\"✗\"\u003e\u003cspan\u003e \u003c\/span\u003eInconsistent\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSame-Day USA Fulfillment\u003c\/td\u003e\n\u003ctd class=\"lp-col\"\u003e\n\u003cimg loading=\"lazy\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table_tick.svg\" alt=\"✓\"\u003e\u003cspan\u003e \u003c\/span\u003eBefore 4PM PST\u003c\/td\u003e\n\u003ctd class=\"gv-col\"\u003e\n\u003cimg loading=\"lazy\" src=\"https:\/\/licensedpeptides.com\/wp-content\/themes\/Avada-Child-Theme\/assets-new\/images\/table-cross.svg\" alt=\"✗\"\u003e\u003cspan\u003e \u003c\/span\u003e3-10 Day Lead Time\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"faq-section\"\u003e\n\u003cdiv class=\"container-new\"\u003e\n\u003cdiv class=\"text-lg-center\"\u003e\n\u003cspan class=\"faq-tag\"\u003eResearch Questions\u003c\/span\u003e\n\u003ch2 class=\"faq-title\"\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row justify-content-center\"\u003e\n\u003cdiv class=\"col-md-8\"\u003e\n\u003cdiv class=\"faq-wrap\"\u003e\n\u003cdiv class=\"accordion faq-accordion\" id=\"faqAccordion\"\u003e\n\u003cdiv class=\"accordion-item\"\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_0\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_0\" aria-expanded=\"true\" aria-controls=\"faqCollapse_0\"\u003e\u003cspan class=\"faq-q\"\u003e1. What is Semax used for in research?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_0\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_0\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eIt is used as a research tool in laboratory studies examining peptide behavior and cellular signaling.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_1\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_1\" aria-expanded=\"true\" aria-controls=\"faqCollapse_1\"\u003e\u003cspan class=\"faq-q\"\u003e2. Is this product approved for medical use?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_1\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_1\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eNo. This compound has not been approved by the FDA or any regulatory authority for therapeutic or clinical use.\u003c\/p\u003e\n\u003ch2 class=\"accordion-header\" id=\"faqHeading_2\"\u003e\u003cbutton class=\"accordion-button faq-button\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqCollapse_2\" aria-expanded=\"true\" aria-controls=\"faqCollapse_2\"\u003e\u003cspan class=\"faq-q\"\u003e3. Who is this product intended for?\u003c\/span\u003e\u003cspan class=\"faq-icon\" aria-hidden=\"true\"\u003e\u003ci class=\"fa-solid fa-chevron-down\"\u003e\u003c\/i\u003e\u003c\/span\u003e\u003c\/button\u003e\u003c\/h2\u003e\n\u003cdiv id=\"faqCollapse_2\" class=\"accordion-collapse collapse show\" aria-labelledby=\"faqHeading_2\" data-bs-parent=\"#faqAccordion\"\u003e\n\u003cdiv class=\"accordion-body faq-body\"\u003e\n\u003cp\u003eThis product is intended for qualified research professionals conducting scientific investigation in controlled laboratory environments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"mysite","offers":[{"title":"10 Vials","offer_id":51786433069373,"sku":null,"price":230.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0997\/4474\/3741\/files\/SEMAX-compressed.jpg?v=1780466219"}],"url":"https:\/\/carmonapettoys.shop\/collections\/moom.oembed","provider":"ISRAEL ISAIAH SCOTT","version":"1.0","type":"link"}